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CHAPTER I 
 
 
INTRODUCTION 
 
1.1 Motivation of Research 
 A rare variant is a Single Nucleotide Polymorphism (SNP) with a minor allele frequency 
(MAF) of 5% or less.  Approximately 60% of human SNPs are rare variants (Gorlov, Gorlova, 
Sunyaev, Spitz, & Amos, 2008).  A debate is playing out as to whether these low frequency 
mutations are important in disease susceptibility (Schork, Murray, Frazer, & Topol, 2009).  
Including rare variants will cost more in terms of money and time as well as make the analysis 
more complex (Hirschhorn & Daly, 2005).  New rapid genotyping technologies now make it 
possible to efficiently survey these rare variants.  Many new statistical methods (Asimit & 
Zeggini, 2010; Bansal, Ondrej, Torkamani, & Schork, 2010) are being developed to analyze the 
associations between rare variants and phenotypes.  Current methods have focused on 
dichotomous phenotypes such as case/control status or quantitative phenotypes such as weight or 
cholesterol level.  The power of these methods depends on the underlying genetic model (Basu & 
Pan, 2011).  Rare variant association methods for multinomial phenotypes, or categorical 
outcomes with more than two possibilities, have not been adequately addressed.  There is one 
published method that can be used for rare variant association when the phenotype is 
multinomial.  This method is the Allele Matching Empirical Locus-specific Integrated 
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Association (AMELIA) method (Zeggini & Asimit, 2010).  However this method has not been 
evaluated using multinomial phenotypes.  It is a modification of the Kernel Based Association Test 
(KBAT) (Mukhopadhyay, Feingold, Weeks, & Thalamuthu, 2010).  The limited simulations on the 
AMELIA test using case control data showed it had a lower power than the KBAT.   
Multinomial phenotypes have occurred in an association study where rare variants were 
included (Sulem, et al., 2007).  Examples of these phenotypes would be hair color, eye color, 
schizophrenia sub-classification, and treatment outcome.  New statistical methods of association need 
to be developed for rare variant association analysis when the phenotype is multinomial. Such a 
method could also be extremely useful in testing for population stratification of rare variants. 
This dissertation proposes and investigates several methods for rare variant association 
analysis when the phenotype is multinomial.  The recommendations contained in a later chapter aid 
geneticists in planning studies and analyzing this type of data.  This work also provides a starting 
point for future researchers to build their own rare variant association methods for multinomial 
phenotypes.   
Sections 1.1.1 through 1.1.3 begins by introducing the background in genetics needed to 
understand the work.  Section 1.2 describes the statistical problems encountered when including rare 
variants in an association study.  Section 1.3 outlines the relevant statistical methods currently 
available.  Section 1.4 reveals the proposed work.  Chapter 2 details the proposed methods.  Chapter 3 
lays out the simulation study of the proposed methods.  Chapter 4 discusses the results of the 
simulation study and makes recommendations on the methods.  Chapter 5 presents the results of 
applying the proposed methods to resequencing data from the Dallas Heart Study.  Chapter 6 provides 
concluding remarks. 
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1.1.1 Common and Complex Disease 
The human genome project finished sequencing the roughly three billion base pairs of the 
human genome in 2003.  Since then there has been a considerable amount of work trying to decode 
what those base pairs do.  Discovering the gene responsible for a simple, or Mendelian, disease is 
straightforward since there is a clear relationship between having the mutated gene responsible for the 
disease and having the disease (Mackay, 2009).  However this relationship does not exist for what are 
called complex diseases.  Here the term penetrance is used to specify the proportion of individuals 
with the gene that exhibit the disease.  Not every individual with the gene will develop the disease.  
Rather an individual with the gene will have a greater probability of developing the disease.  Further 
convoluting the ability to detect genes responsible for complex diseases is allelic heterogeneity, or the 
presence of different mutations at a single locus that produce the same phenotype.  A common disease 
is a disease that occurs frequently in the population.  It is usually assumed that common diseases have 
a complex genetic structure and hence fall under the domain of complex diseases.  These common 
diseases include cancer, diabetes, and schizophrenia as well as many others.  Common diseases are 
the focus of the rest of this paper. 
1.1.2 The Common Disease Common Variant Hypothesis 
There are two separate hypotheses used by current researchers trying to discover the genetic 
components of common diseases.  The first is the Common Disease Common Variant (CDCV) 
hypothesis.  It states that a common disease is the result of one or a few common variants with high 
penetrances in the genome (Reich & Lander, 2001; Pritchard & Cox, 2002; Schork, Murray, Frazer, 
& Topol, 2009).  Supporters of this line of thinking argue that interactions between a small number of 
alleles produce the disease prevalence seen in the population (Smith & Lusis, 2002).  Many early 
studies adopted this hypothesis because it required a smaller number of observations and markers to 
detect associations.  If the CDCV hypothesis is true then with a reasonable sample size current 
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methods of association and linkage analysis should have adequate power to detect a locus responsible 
for a disease (Risch & Merikangas, 1996).  The power of linkage disequilibrium mapping is low 
when common alleles have low penetrance (Hirschhorn & Daly, 2005).  
1.1.3 The Common Disease Rare Variant Hypothesis 
The second hypothesis is the Common Disease Rare Variant (CDRV) hypothesis.  For this 
study a rare variant is defined as an allele that has a MAF of 5% or less.  Some authors define a rare 
variant as an allele that has a MAF of 1% or less (Li & Leal, 2008; Morris & Zeggini, 2010).  The 
CDRV hypothesis states that a number of rare variants and possibly several common variants are 
responsible for the disease (Schork, Murray, Frazer, & Topol, 2009).  These variants have moderate 
to high penetrances (Li & Leal, 2008).   Some researchers assume the variants are independent in the 
CDRV hypothesis (Li & Leal, 2008).  While others assume a dependency called linkage 
disequilibrium (LD), or the phenomenon where a string of DNA tends to be inherited together, is 
present (Madsen & Browning, 2009; Basu & Pan, 2011). 
The difference between two above hypotheses amounts to whether to include or exclude rare 
variants.  A large multi-database study concluded that approximately 60% of human SNPs have a 
MAF of less than 5% (Gorlov, Gorlova, Sunyaev, Spitz, & Amos, 2008).  Yet most studies using 
association methods or linkage mapping are not adequately powered to detect associations with 
variants with a low MAF (Risch & Merikangas, 1996).  Commercially available SNP platforms 
exclude most rare variants (Zeggini & Asimit, 2010).  It is common for studies to not follow up on 
significant SNPs when the MAF is less than 5% (Asimit & Zeggini, 2010, p. 294).  Pritchard showed 
at least theoretically through simulations that rare and common variants could contribute to the 
genetic variation of a complex disease (2001).  The combined results of several simulation studies 
show that for the low penetrance and high allelic heterogeneity seen in many common diseases, the 
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frequency of alleles responsible for that common disease will be near zero or one (Pritchard & Cox, 
2002).   
Some researchers are beginning to adopt the CDRV hypothesis.  A review of all human 
genome wide association studies (GWAS) published up to December 2009 found 43 significant 
associations involving a rare variant with a p-value of 10-7 or less in 28 different studies (Panagiotou, 
Evangelou, & Ioannidis, 2010).  It is important to note that the average sample size of these studies 
was 10,647 individuals.   
1.2 Difficulties with Including Rare Variants 
Since including rare variants means adding many more markers to an analysis, false 
discovery rates, degrees of freedom, and power become problematic.  It has been shown by many 
researchers that single marker analysis adjusted to control the family-wise error rate (FWER) suffers 
from extremely low power to detect a true association (Li & Leal, 2008; Madsen & Browning, 2009; 
Basu & Pan, 2011).  Even with a reasonable FWER control many false positives may still occur.  
Multivariate analysis such as a Hotelling’s T2 test or multiple logistic regression has slightly higher 
power in these studies but it is still not adequate (Li & Leal, 2008).  Since the degrees of freedom in 
the likelihood ratio test of the multiple logistic regression and the numerator degrees of freedom in 
the Hotelling’s T2 test statistic are equal to the number of markers, a large number of markers results 
in a large number degrees of freedom in these tests.  This makes it difficult to detect a true 
susceptibility allele hence reducing the power in these tests. 
Sample size also becomes a huge consideration when including rare variants.  As previously 
mentioned Panagiotou, Evangelou, and Ioannidis (2010) found that published studies that discovered 
a significant rare variant had an average sample size of 10,647.  It has also been shown that for case 
control studies the sample size necessary to achieve a fixed power increases as MAF decreases 
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(Gorlov, Gorlova, Sunyaev, Spitz, & Amos, 2008).  These increases are more dramatic for rare 
variants with marginal effects. 
It has been argued that current methods based on LD are inadequate for rare variant analysis 
(Asimit & Zeggini, 2010).  This stems from the fact that for a strong correlation to exist the MAFs of 
the two variants must be roughly equal (VanLiere & Rosenberg, 2008).  Commercially available SNP 
platforms rely on LD to balance the number of SNPs with the amount of genetic variation captured. 
Since these panels include very few rare variants the ability to detect a causal rare variant is low using 
them. 
1.3 Methods for Detecting Associations with Rare Variants 
Including rare variants in the search for an association has necessitated the development of 
new statistical methods.  While most of the methods available for rare variant association analysis are 
for case control data or a dichotomous response there are some methods for quantitative phenotypes 
(Asimit & Zeggini, 2010).  To date there is only one published method for rare variant analysis when 
the phenotype is multinomial.  Methods for quantitative phenotypes will be discussed first, followed 
by case control data, and lastly multinomial phenotypes. 
1.3.1 Quantitative Phenotypes 
A few methods exist for rare variant association analysis when the phenotype is quantitative.  
Morris and Zeggini (2010) present two methods based on linear regression.  Price and authors (2010) 
propose a variable threshold approach that considers multiple threshold cutoffs at once.  Hoffman, 
Marini, and Witte (2010) illustrate a step-up procedure to build a model relating the quantitative 
phenotype to the variants.  Thalamuthu, Zhao, Keong, Kondragunta, and Mukhopadhyay (2011) have 
extended their previous Kernel-Based Association Test (KBAT) (Mukhopadhyay, Feingold, Weeks, 
& Thalamuthu, 2010) so that quantitative phenotypes could be analyzed.  The new Quantitative Trait 
Kernel Based Association Test (QT-KBAT) and the original KBAT are also modified to better handle 
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rare variants included with common variants in the test.  The simulations for Morris and Zeggini’s 
methods, the variable threshold approach, and the step-up procedure only considered a normally 
distributed phenotype.  The QT-KBAT method was only applied to a single generated data set.  
Hence the behavior of these tests is unknown when the phenotype is non-normal.  Also the variable 
threshold approach, step-up procedure, and quantitative kernel-based association test are all very 
computationally intensive.   
1.3.2 Case Control Designs 
 The majority of the research in rare variant association published to date is for case control 
designs (Asimit & Zeggini, 2010).  In general there is not one method that performs best under all 
situations (Basu & Pan, 2011).  Rather the performance of each of the methods depends on the 
underlying genetic model.    The following pages will lay out some of the available association 
methods for case control designs.  
 The first group of methods considered here are the model type methods.  These methods 
usually have many degrees of freedom in the test or require an adjustment for multiple tests.  A 
majority of the tests are based on the generalized linear model for case control data via multiple 
logistic regression.  Since the degrees of freedom is equal to the number of variants in the model, this 
test can have a large number of degrees of freedom if a large number of variants are used.  Li and 
Leal (2008) found that multiple logistic regression had an inflated Type I Error rate as a method for 
rare variant association.  Han and Pan (2010) proposed the adaptive sum test to strike a balance 
between large number of degrees of freedom in the multiple logistic regression test and large 
adjustment for multiple tests.  The step-up procedure (Hoffmann, Marini, & Witte, 2010) mentioned 
above can also be used for a dichotomous phenotype.  This procedure builds a logit model using a 
step-up algorithm.  Both the adaptive sum test and step-up procedure aim to limit the number of 
variants used in the logit model but still require a large number of degrees of freedom.  The univariate 
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minP test which tests a logit model with each variant individually was considered in simulations by 
Basu and Pan (2011).  This procedure requires a large adjustment for multiple tests.    
Several methods seek to reduce the dimensionality of the data and hence preserve the degrees 
of freedom in the test (Asimit & Zeggini, 2010).  This should theoretically increase the power of the 
tests at the one locus where the combining of the data is made.  Since these methods collapse or pool 
rare variants together they are often called collapsing or pooling methods. 
The Combined Multivariate and Collapsing (CMC) method proposed by Li and Leal groups 
markers by MAF at a locus and collapses within groups by creating a single dummy variable for the 
group (2008).  A Hotellings T2 test is then performed on the collapsed data and any other high 
frequency variants included.  The authors show through simulations that the CMC method has higher 
power than a single marker analysis and the Hotelling’s T2 test without collapsing.  Additionally the 
CMC method controls the Type I error at the desired level. 
A weighted sum statistic (WSS) presented by Madsen and Browning (2009) also combines 
markers within a locus to test for association with rare variants.  In this method the number of rare 
alleles is weighted by the inverse of the standard deviation of the number of rare alleles.  A “genetic 
score” is created for each individual by summing up the weighted number of rare alleles.  The sum of 
the ranks of the genetic scores in cases is then used in a permutation test.  The researchers show 
through simulations that their test has improved power over the CMC method and a single marker 
analysis.   
 Although the WSS and Li and Leal’s CMC method have been the benchmark methods that 
most researchers compare their proposed case control methods to, many other methods also use 
collapsing or pooling to achieve better power.  Feng, Elson, and Zhu (2011) propose a modification to 
Madsen and Browning’s WSS.  They adjust the weight for both sib-pair and case control designs.  
The variable threshold test for quantitative phenotypes previously mentioned can also be applied to 
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dichotomous phenotypes (Price, et al., 2010).  This method considers multiple thresholds for 
collapsing rare variants.  Ionita-Laza, Buxbaum, Laird, and Lange (2011) propose the Replication 
Based Test that groups variants together by minor allele counts.  The Kernel Based Adaptive Cluster 
(KBAC) test (Liu & Leal, 2010) pools individuals together with the same rare variant haplotype and 
looks for differences in the proportions in cases and controls.  The Cumulative Minor-Allele Test 
(CMAT) (Zawistowski, Gopalakrishnan, Ding, Li, Grimm, & Zollner, 2010) pools allele counts for 
cases and controls.  The Kernel Based Association Test (KBAT) for case control data is modified to 
better handle rare variants (Thalamuthu, Zhao, Keong, Kondragunta, & Mukhopadhyay, 2011).  Rare 
variants are pooled to increase power and decrease computation time.   The C-alpha test (Neale, et al., 
2011) uses the distribution between cases and controls of individuals with a rare variant.  Markers are 
pooled by summing over the markers in the locus.   
 A number of methods for analysis of common variants are suggested for rare variant analysis.  
Some of these methods include the kernel-machine test (Wu, et al., 2010), Hotelling’s T2 test (Li & 
Leal, 2008), the SSU test (Basu & Pan, 2011), the Sum test (Basu & Pan, 2011), multivariate distance 
matrix regression (MDMR) (Wessel & Schork, 2006), the ZGlobal Statistic (Schaid, McDonnell, 
Hebbring, Cunningham, & Thibodeau, 2005), Logic regression, ridge regression, and LASSO.  Most 
but not all of these methods are evaluated in simulation studies where rare variants are included as 
both causal and non-causal variants. 
1.3.3 Multinomial Methods 
 To date there is only one method as proposed available for rare variant association testing 
when more than two phenotypic categories are present.  This method is called the Allele Matching 
Empirical Locus-specific Integrated Association (AMELIA) test (Zeggini & Asimit, 2010).  It is a 
modification of the original KBAT method by Mukhopadhyay, Feingold, Weeks, and Thalamughu 
(2010) mentioned above.  The AMELIA method includes genotype quality scores and allows for 
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more than two categories in the phenotype.  The researchers only compare their AMELIA test to the 
original KBAT method on case control data.  Multinomial phenotypes are not used in any of the 
simulations.  Both methods have very low power to detect a true association in the case control data.  
When a region of 342 simulated SNPs is included in the test, the AMELIA test has a power of 8.71% 
and the KBAT has a power of 9.53%.  When a neighborhood of 11 SNPs around the one causal SNP 
is considered the AMELIA test has a power of 17.31% and the KBAT method has a power of 
21.61%.  These limited simulations show that the KBAT test has higher power than the AMELIA 
test.  Additionally the AMELIA test requires SNP quality scores which may not be available.  Thus 
the AMELIA test is not further considered. 
The KBAT method for case control data described above is laid out generally so that more 
than two categories in the phenotype are possible.  However the test statistic used forces two 
categories and an equal number of observations in each category.  The test statistic is easily modified 
to allow for more than two categories and an unbalanced design as was done for the AMELIA test.  
There are no power estimates available for rare variant analysis with multinomial phenotypes in the 
published literature.  Early work on this dissertation considered this modified KBAT method.  An 
attempt to analyze one data set with 320 variants and 1000 individuals on one node of the super 
computer Pistol Pete timed out after 24 hours.  Since 1,000 iterations would need to be run, it was 
decided the method was too computationally intensive to include in the simulation study.  This 
method could be considered in a future simulation study with a much smaller number of individuals 
and SNPs.   
In the study of more than two phenotypic categories, it is possible to collapse to two 
categories and proceed with a case control method.  However information is lost when this is done 
and the results depend on which categories are collapsed.  Another possibility is using a stratified 
approach.  A stratified single marker analysis is used by Sulem et al. (2007) for an analysis of hair 
and eye color.  However the power of these types of approaches to detect a true association has not 
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been evaluated.  Morris and Zeggini’s methods, the threshold tests, the step-up procedure, and the 
QT-KBAT method detailed in section 1.3.1 for quantitative phenotypes can also be used to test for an 
association when the phenotype is categorical.  All of these methods can be applied to the 
multinomial phenotype data as long as the categories are coded as a number.  The methods provided 
by Morris and Zeggini (2010) assume a normal distribution which is violated in the case of 
categorical phenotypes.  The threshold tests, QT-KBAT, and the step-up test use permutations so the 
departure from normality should not be a problem.  However none of these methods have been 
evaluated when the phenotype is a non-normal distribution such as the multinomial distribution.  
Additionally each of these methods is extremely computationally extensive.  In the interest of time 
and brevity none of the quantitative phenotype methods are considered as a method of association 
with a multinomial phenotype.  Proposed methods of association are laid out in the next section. 
1.4 Scope of Study 
It is plausible that rare variants are responsible in some part for common diseases 
(Panagiotou, Evangelou, & Ioannidis, 2010; Pritchard, 2001; Pritchard & Cox, 2002; Schork, Murray, 
Frazer, & Topol, 2009).  Current methods for testing for an association with a nominal response are 
lacking.  Therefore three novel methods of rare variant analysis for genetic data with a multinomial 
response are investigated.  The first method is an extension of the weighted sum statistic by Madsen 
and Browning (2009).  A test statistic for the weighted sum statistic procedure is chosen that can 
incorporate more than two outcomes in the phenotype.  A single marker analysis (SMA) is created to 
work with multinomial data.  A test procedure is developed and the appropriate test statistic is 
determined for each test of association at each marker.  Then a multiple testing procedure is necessary 
to adjust for the large number of tests being run.  Finally the results of all of these tests are put 
together for a single decision about the association at the locus.  Finally multinomial logistic 
regression is investigated as a method of association.  This method is the generalized linear model 
approach so it should be a good baseline for comparison.  The appropriate test statistic is taken from 
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the literature as multinomial logistic regression is a published procedure.  All of the methods are 
developed and evaluated so that recommendations can be made on how to run a rare variant analysis 
when the phenotype is multinomial.   
Simulations are run to assess the performance of each of the methods.  First genetic data is 
generated.  To determine the Type I Error rate, data is produced under the null hypothesis of no 
association.  To determine the power data is simulated under the alternative hypothesis of an 
association between the phenotype and SNPs.  The proposed methods are applied to these data sets to 
detect an association between the markers and phenotypes.  The results are recorded and presented in 
later chapters of this document.  Recommendations based on the simulations are presented. 
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CHAPTER II 
 
 
METHODOLOGY 
 
 This chapter outlines the three proposed methods for testing for an association between a 
multinomial phenotype and multiple rare variants.  In general it is assumed that the Common 
Disease Rare Variant hypothesis detailed in Section 1.1.3 holds.  The first method considered is 
the weighted sum statistic for multinomial data (see Section 2.1).  This is followed by a single 
marker analysis (see Section 2.2).  A false discovery rate controlling method is included for the 
single marker analysis (see Section 2.2.1).  Multinomial logistic regression is considered as a 
method to test for association (see Section 2.3).  The multinomial logistic regression routine fails 
to fit the model at times.  Due to these failures, collapsing of variants in the multinomial logistic 
regression procedure is also considered (see Section 2.4).  The terms variant and marker are used 
interchangeably in this document. 
2.1 A Weighted Sum Statistic for Multinomial Data 
A weighted sum statistic is proposed to test for an association between a multinomial 
response and collectively all rare variants at a locus.  Markers along a chromosome must first be 
grouped into a locus or gene where the test is to be conducted.  Rare variants within the locus will 
be pooled together in the test.  Following the lead of other researchers it is assumed that this 
grouping can be done in a meaningful way (Li & Leal, 2008; Madsen & Browning, 2009).  Since 
multiple loci or genes are tested in a GWAS, a multiple testing control must be used to control 
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either the familywise experiment rate or the false discovery rate.  The hypotheses to test for an 
association at one locus are: 
H0: The mutation frequency is the same for all response groups (k = 1, …, K). 
Ha: The mutation frequency is different for at least one of the response groups. 
These hypotheses are equivalent to testing for association between the multinomial response and 
the variants at a locus since the frequency of the alleles are the same for each response group if 
there is no association.  The test consists of the following steps: 
1. For each variant or marker, j = 1, …, J, identify the mutant allele that is thought to be a 
susceptibility allele.  If it is not known which allele is the mutant one then the rarer allele 
will be used. 
2. Next a weight is calculated for each genotype.  Define mj as the number of mutant alleles 
in individuals at variant j and 𝑛∙𝑗 as the number of individuals genotyped for variant j.  
Since each individual is genotyped on a pair of chromosomes there are 2 ∙ 𝑛∙𝑗 alleles for 
each marker.  The weight is  
𝑤𝑗 = �𝑛∙𝑗𝑞𝑗�1 − 𝑞𝑗� 
where 
𝑞𝑗 = 𝑚𝑗 + 12𝑛∙𝑗 + 2. 
Thus qj is the adjusted frequency of mutant alleles at marker j.  The weight is the standard 
deviation of the number of mutant alleles using pseudo counts.  The adjustment in qj is 
necessary since the frequency of mutant alleles is expected to be small possibly zero.  In 
a future step a quantity is calculated where 𝑤𝑗 is used in the denominator.  Hence it is 
undesirable for 𝑤𝑗 to be zero.  Individuals missing the phenotype but possessing 
genotypic information are allowed to contribute to the weights.   
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3. Define Iijk as the number of mutant alleles in variant j for individual i in group k.  Since 
each individual has two copies of each chromosome for an additive model 𝐼𝑖𝑗𝑘 ∈ {0, 1, 2}.  
However if a recessive or dominant model is expected then restrict 𝐼𝑖𝑗𝑘 ∈ {0, 1}.  For the 
recessive model only the homozygous mutants receive a 1.  For the dominant model both 
the heterozygous and homozygous mutants receive a 1.  The additive model is the default 
model used.  Any individual which is missing the multinomial response or all genetic 
markers must be eliminated from further calculations.  For the remaining individuals any 
missing Iijk is assumed to be zero. For each individual calculate the genetic score 
following Madsen and Browning (2009) as 
𝛾𝑖𝑘 = �𝐼𝑖𝑗𝑘𝑤𝑗𝐽𝑗=1 . 
Hence the genetic score is the weighted sum of the number of mutations in each 
individual.  The lower the mutant allele frequency in the sample, the more a mutation at 
that variant contributes to the genetic score.  This allows a mutation at a variant with an 
allele frequency of 1% to contribute more to the genetic score than a mutation at a variant 
with a 5% allele frequency.  It also allows a mutation at a rare variant to contribute more 
than a mutation at a common variant if common variants are included in the test. 
4. Using the genetic scores, 𝛾𝑖𝑘’s, conduct a Kruskal-Wallis test to detect a difference in the 
distribution of the genetic scores between response groups.  A test statistic assuming ties 
is necessary since ties in the genetic scores are possible.  For a tie the average of the 
ranks is assigned.   
5. An observed significance level is obtained either using the asymptotic chi-square 
distribution of the test statistic or through a permutation test.  The method used depends 
on whether it is assumed that the observations are independent or not.  If it can be 
assumed that the observations are independent, then the observed significance level is the 
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probability that a chi-square random variable with K-1 degrees of freedom is greater than 
the test statistic, T.  If it is assumed that there is dependence among the observations, an 
empirical distribution for T is found by permuting the response group among individuals 
and recalculating the test statistic at least 1000 times.  The observed significance level of 
the test statistic is the percentile of the observed test statistic in the empirical distribution.  
2.1.1 The Distribution of the Weights and Genetic Scores 
 The proposed Multinomial Weighted Sum Statistic utilizes the Kruskal-Wallis test 
statistic to test for an association between all rare variants collectively and the phenotype.  This is 
not necessary if the distribution of the genetic scores is known or the central limit theorem applies 
to the sum in the genetic score.  Since the genetic score is a sum of ratios it is not unreasonable to 
expect the central limit theorem to apply.  An empirical study of the genetic scores showed that 
the data is very far from normal.  One thousand data sets were generated using the procedure 
described in chapter 3.  The genetic score was calculated for each individual in each of the data 
sets.  Lilliefors test for Normality (Conover, 1999, p. 443) and the Shapiro-Wilk test for 
Normality (Conover, 1999, p. 450) were both run on each data set to test the null hypothesis that 
the data is normally distributed.  All one thousand times the null hypothesis was rejected for both 
tests.  This provides strong evidence that the central limit theorem does not apply.  Inspection of 
the generated genetic scores revealed that the distribution is skewed and large outliers are 
possible.  Feng, Elson, and Zhu (2011) also reported finding the distribution of the genetic scores 
skewed with possible outliers. 
 Additionally the distribution of the genetic scores is currently unknown.  However it is 
possible to derive the distributions of some of the quantities input into the genetic score.  These 
derivations are produced as part of the work of this dissertation.  For all derivations shown here 
individuals and markers are considered independent.  This may not be the case if pedigree 
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structure or linkage disequilibrium exists.  Let 𝑛∙𝑗 be the number of individuals genotyped for 
variant j.  Also let 𝑁𝑘 be the number of individuals in response group k.  Assuming an additive 
model, use Iijk as the number of mutant alleles at variant j for individual i of group k as before.  
Also assume a fixed probability of a mutant allele at variant j, 𝑝𝑗, in the population.  Then 
𝐼𝑖𝑗𝑘~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙�𝑛 = 2,𝑝 = 𝑝𝑗�.  Now fix j and consider the mutations at variant j.  Since the 
individuals are assumed independent the joint distribution of the Iijk ‘s at variant j is   
𝑓�𝐼1𝑗1, 𝐼2𝑗1, … , 𝐼𝑁𝐾𝑗𝐾� = � � 2𝐼𝑖𝑗𝑘�
𝑖,𝑘 � ∙ 𝑝𝑗∑ 𝐼𝑖𝑗𝑘𝑖,𝑘 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−∑ 𝐼𝑖𝑗𝑘𝑖,𝑘 . 
Consider the joint transformation 
𝑦1 = �𝐼𝑖𝑗𝑘
𝑖,𝑘 , 
𝑦2 = 𝐼1𝑗1, 
𝑦3 = 𝐼2𝑗1, …,  
𝑦𝑛∙𝑗 = 𝐼(𝑁𝐾−1)𝑗𝐾 . 
Then the joint distribution of the 𝑦𝑖’s is 
𝑓 �𝑦1,𝑦2, … ,𝑦𝑛∙𝑗� = � 2𝑦2� ∙ � 2𝑦3� ∙ … ∙ � 2𝑦𝑛∙𝑗� ∙ � 2𝑦1 −�𝑦𝑎𝑛∙𝑗
𝑎=2
� ∙ 𝑝𝑗
𝑦1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−𝑦1 
where 𝑦𝑎 ∈ {0,1,2} for 𝑎 = 2, 3, … ,𝑛∙𝑗 and 𝑦1 − ∑ 𝑦𝑎𝑛∙𝑗𝑎=2 ∈ {0,1,2}.  Notice that 𝑦1 is dependent 
on the 𝑦𝑎’s since there is no way to factor the joint distribution.  Therefore the weights in the 
genetic score which are a function of 𝑦1 will also be dependent on the 𝐼𝑖𝑗𝑘’s.  Randomly choose 
one of the 𝑦𝑎’s 𝑎 = 2, 3, … , 𝑛∙𝑗  to keep.  For convenience 𝑦2 is used in the following derivations 
18 
 
but any 𝑦𝑎, 𝑎 = 2, 3, … ,𝑛∙𝑗 can be chosen.  It is desired to find the joint distribution of 𝑦1,𝑦2.  
First find the marginal joint distribution of 𝑦1,𝑦2, … ,𝑦𝑛∙𝑗−1.  
𝑓 �𝑦1,𝑦2, … ,𝑦𝑛∙𝑗−1�
= � 2𝑦2� ∙ � 2𝑦3� ∙ … ∙ � 2𝑦𝑛∙𝑗−1� ∙ 𝑝𝑗𝑦1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−𝑦1 ∙ � 4𝑦1 − � 𝑦𝑎𝑛∙𝑗−1
𝑎=2
�
∙ �
�
2
𝑦𝑛∙𝑗
� ∙ �
2
𝑦1 − �∑ 𝑦𝑎
𝑛∙𝑗−1
𝑎=2 � − 𝑦𝑛∙𝑗
�
�
4
𝑦1 − ∑ 𝑦𝑎
𝑛∙𝑗−1
𝑎=2
�
𝑚𝑖𝑛�2,𝑦1−∑ 𝑦𝑎𝑛∙𝑗−1𝑎=2 �
𝑦𝑛∙𝑗=𝑚𝑎𝑥�0,𝑦1−∑ 𝑦𝑎𝑛∙𝑗−1𝑎=2 �
 
= � 2𝑦2� ∙ � 2𝑦3� ∙ … ∙ � 2𝑦𝑛∙𝑗−1� ∙ 𝑝𝑗𝑦1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−𝑦1 ∙ � 4𝑦1 − � 𝑦𝑎𝑛∙𝑗−1
𝑎=2
� 
where 𝑦𝑎 ∈ {0,1,2} for 𝑎 = 2, 3, … ,𝑛∙𝑗 − 1 and 𝑦1 − ∑ 𝑦𝑎𝑛∙𝑗−1𝑎=2 ∈ {0,1,2, 3, 4} since  
�
2
𝑦𝑛∙𝑗
� ∙ �
2
𝑦1 − ∑ 𝑦𝑎
𝑛∙𝑗−1
𝑎=2 − 𝑦𝑛∙𝑗
�
�
4
𝑦1 − ∑ 𝑦𝑎
𝑛∙𝑗−1
𝑎=2
�
~𝐻𝑦𝑝𝑒𝑟𝑔𝑒𝑜𝑚𝑒𝑡𝑟𝑖𝑐(𝑛,𝑀,𝑁) 
with 𝑛 = 𝑦1 − ∑ 𝑦𝑎𝑛∙𝑗−1𝑎=2 , 𝑀 = 2, and 𝑁 = 4 (Bain & Engelhardt, 1992, p. 96).  Continuing find 
the joint distribution of 𝑦1,𝑦2, … ,𝑦𝑛∙𝑗−2.   
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𝑓 �𝑦1,𝑦2, … ,𝑦𝑛∙𝑗−2�
= � 2𝑦2� ∙ � 2𝑦3� ∙ … ∙ � 2𝑦𝑛∙𝑗−2� ∙ 𝑝𝑗𝑦1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−𝑦1 ∙ � 6𝑦1 − � 𝑦𝑎𝑛∙𝑗−2
𝑎=2
�
∙ �
�
2
𝑦𝑛∙𝑗−1
� ∙ �
4
𝑦1 − �∑ 𝑦𝑎
𝑛∙𝑗−2
𝑎=2 � − 𝑦𝑛∙𝑗−1
�
�
6
𝑦1 − ∑ 𝑦𝑎
𝑛∙𝑗−2
𝑎=2
�
𝑚𝑖𝑛�2,𝑦1−∑ 𝑦𝑎𝑛∙𝑗−2𝑎=2 �
𝑦𝑛∙𝑗−1=𝑚𝑎𝑥�0,𝑦1−∑ 𝑦𝑎𝑛∙𝑗−2𝑎=2 �
 
= � 2𝑦2� ∙ � 2𝑦3� ∙ … ∙ � 2𝑦𝑛∙𝑗−2� ∙ 𝑝𝑗𝑦1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−𝑦1 ∙ � 6𝑦1 − � 𝑦𝑎𝑛∙𝑗−2
𝑎=2
� 
where 𝑦𝑎 ∈ {0,1,2} for 𝑎 = 2, 3, … ,𝑛∙𝑗 − 2 and 𝑦1 − ∑ 𝑦𝑎𝑛∙𝑗−2𝑎=2 ∈ {0, 1, 2, 3, 4, 5, 6}.  By induction 
continuing this process until only the joint distribution of 𝑦1 and 𝑦2 remains finds 
𝑓(𝑦1,𝑦2) = � 2𝑦2� ∙ �2�𝑛∙𝑗 − 1�𝑦1 − 𝑦2 � ∙ 𝑝𝑗𝑦1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−𝑦1 
where 𝑦2 ∈ {0, 1, 2} and 𝑦1 ∈ �𝑦2, … , 2�𝑛∙𝑗 − 1� + 𝑦2�.  Notice that if the process had also 
summed out 𝑦2 the resulting marginal distribution of 𝑦1 would be 
𝑓(𝑦1) = �2𝑛∙𝑗𝑦1 � ∙ 𝑝𝑗𝑦1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗−𝑦1 . 
Hence the distribution of the sum of the mutant alleles at variant j is 𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙�𝑛 = 2𝑛∙𝑗,𝑝 =
𝑝𝑗�.  Now consider the following joint transformation of 𝑓(𝑦1,𝑦2): 
𝑞𝑗1 = 𝑦1 + 12𝑛∙𝑗 + 2, 
𝑞𝑗2 = 𝑦2. 
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Then the joint distribution of 𝑞𝑗1 and 𝑞𝑗2 is 
𝑓�𝑞𝑗1, 𝑞𝑗2� = � 2𝑞𝑗2� ∙ � 2�𝑛∙𝑗 − 1�𝑞𝑗1�2𝑛∙𝑗 + 1� − 1 − 𝑞𝑗2� ∙ 𝑝𝑗𝑞𝑗1�2𝑛∙𝑗+2�−1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−𝑞𝑗1�2𝑛∙𝑗+2� 
Where 𝑞𝑗2 ∈ {0, 1, 2} and 𝑞𝑗1 ∈ � 𝑞𝑗2+12𝑛∙𝑗+2 , 𝑞𝑗2+22𝑛∙𝑗+2 , … , 2�𝑛∙𝑗−1�+𝑞𝑗2+12𝑛∙𝑗+2 �.  Now consider the joint 
transformation  
𝑤𝑗1 = �𝑛∙𝑗𝑞𝑗1�1 − 𝑞𝑗1� 
𝑤𝑗2 = 𝑞𝑗2. 
The equation for 𝑤𝑗1 is not one to one and has a maximum at 1 2⁄ .  Using the quadratic formula 
to solve for 𝑞𝑗1 yields 
𝑞𝑗1 = 12 �1 ± �1 − 4𝑤𝑗12 𝑛∙𝑗� �. 
Now define 𝐴1 = � 𝑞2+12𝑛∙𝑗+2 , 𝑞2+22𝑛∙𝑗+2 , … , 12� and 𝐴2 = � 𝑛∙𝑗+22𝑛∙𝑗+2 , 𝑞2+32𝑛∙𝑗+2 , … , 2�𝑛∙𝑗−1�+𝑞𝑗2+12𝑛∙𝑗+2 �.  Then 𝑤𝑗1 is 
one to one on the sets 𝐴1 and 𝐴2.  On 𝐴1 the inverse is 𝑞𝑗1− = 12 �1 −�1 − 4𝑤𝑗12 𝑛∙𝑗� � and on 𝐴2 
the inverse is 𝑞𝑗1+ = 12 �1 + �1 − 4𝑤𝑗12 𝑛∙𝑗� �.  Define the following sets 
 �𝑤𝑗1,𝑤𝑗2� ∈ 𝐵1 = ���𝑛∙𝑗 � 12𝑛∙𝑗+2� �1 − 12𝑛∙𝑗+2� , 0� ,��𝑛∙𝑗 � 22𝑛∙𝑗+2� �1 − 22𝑛∙𝑗+2� , 0��, 
𝐵2 = ���𝑛∙𝑗 � 2𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 2𝑛∙𝑗2𝑛∙𝑗 + 2� , 2� ,��𝑛∙𝑗 �2𝑛∙𝑗 + 12𝑛∙𝑗 + 2��1 − 2𝑛∙𝑗 + 12𝑛∙𝑗 + 2� , 2�� 
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𝐵3 = ���𝑛∙𝑗 � 32𝑛∙𝑗 + 2��1 − 32𝑛∙𝑗 + 2� , 0� ,��𝑛∙𝑗 � 42𝑛∙𝑗 + 2��1 − 42𝑛∙𝑗 + 2� , 0� , … , 
 ��𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2� , 0�� 
𝐵4 = ���𝑛∙𝑗 � 22𝑛∙𝑗 + 2��1 − 22𝑛∙𝑗 + 2� , 1� , … ,��𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2� , 1�� 
𝐵5 = ���𝑛∙𝑗 � 32𝑛∙𝑗 + 2��1 − 32𝑛∙𝑗 + 2� , 2� ,��𝑛∙𝑗 � 42𝑛∙𝑗 + 2��1 − 42𝑛∙𝑗 + 2� , 2� , … , 
 ��𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2� , 2��. 
𝐵6 = ���𝑛∙𝑗2 , 0� ,��𝑛∙𝑗2 , 1� ,��𝑛∙𝑗2 , 2�� 
If �𝑤𝑗1,𝑤𝑗2� ∈ 𝐵1 then the joint distribution of 𝑤𝑗1 and 𝑤𝑗2 is 
𝑓�𝑤𝑗1,  𝑤𝑗2� = � 2𝑤𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 −�1 − 4𝑤𝑗12 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 −𝑤𝑗2� ∙ 𝑝𝑗�1−�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1−�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1�. 
If �𝑤𝑗1,𝑤𝑗2� ∈ 𝐵2 then the joint distribution of 𝑤𝑗1 and 𝑤𝑗2 is 
𝑓�𝑤𝑗1,  𝑤𝑗2� = � 2𝑤𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 + �1 − 4𝑤𝑗12 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 −𝑤𝑗2� ∙ 𝑝𝑗�1+�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1+�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1�. 
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If �𝑤𝑗1,𝑤𝑗2� ∈ 𝐵3,𝐵4,  or 𝐵5 then the joint distribution of 𝑤𝑗1 and 𝑤𝑗2 is 
𝑓�𝑤𝑗1,  𝑤𝑗2� = � 2𝑤𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 −�1 − 4𝑤𝑗12 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 −𝑤𝑗2� ∙ 𝑝𝑗�1−�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1−�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1� 
+ � 2𝑤𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 + �1 − 4𝑤𝑗12 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 −𝑤𝑗2� ∙ 𝑝𝑗�1+�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1+�1−4𝑤𝑗12 𝑛∙𝑗� ��𝑛∙𝑗+1�. 
If �𝑤𝑗1,𝑤𝑗2� ∈ 𝐵6 then the joint distribution of 𝑤𝑗1 and 𝑤𝑗2 is 
𝑓�𝑤𝑗1,𝑤𝑗2� = � 2𝑤𝑗2� ∙ �2�𝑛∙𝑗 − 1�𝑛∙𝑗 − 𝑤𝑗2 � ∙ 𝑝𝑗𝑛∙𝑗 ∙ �1 − 𝑝𝑗�𝑛∙𝑗 . 
Now consider the joint transformation 
𝑟𝑗1 = 𝑤𝑗2𝑤𝑗1 = 𝐼1𝑗1𝑤𝑗  
𝑟𝑗2 = 𝑤𝑗1. 
Define the sets 
�𝑟𝑗1, 𝑟𝑗2� ∈ 𝐶1
= ��0,�𝑛∙𝑗 � 12𝑛∙𝑗 + 2��1 − 12𝑛∙𝑗 + 2�� ,�0,�𝑛∙𝑗 � 22𝑛∙𝑗 + 2��1 − 22𝑛∙𝑗 + 2��� 
𝐶2 = ��2 �𝑛∙𝑗 � 12𝑛∙𝑗 + 2��1 − 12𝑛∙𝑗 + 2�� ,�𝑛∙𝑗 � 12𝑛∙𝑗 + 2��1 − 12𝑛∙𝑗 + 2�� , 
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�2 �𝑛∙𝑗 � 22𝑛∙𝑗 + 2��1 − 22𝑛∙𝑗 + 2�� ,�𝑛∙𝑗 � 22𝑛∙𝑗 + 2��1 − 22𝑛∙𝑗 + 2��� 
𝐶3 = ��0,�𝑛∙𝑗 � 32𝑛∙𝑗 + 2��1 − 32𝑛∙𝑗 + 2�� ,�0,�𝑛∙𝑗 � 42𝑛∙𝑗 + 2��1 − 42𝑛∙𝑗 + 2�� , … , 
 �0,�𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2��� 
𝐶4 = ��2 �𝑛∙𝑗 � 32𝑛∙𝑗 + 2��1 − 32𝑛∙𝑗 + 2�� ,�𝑛∙𝑗 � 32𝑛∙𝑗 + 2��1 − 32𝑛∙𝑗 + 2�� , , … , 
 �2 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2�� ,�𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2��� 
𝐶5 = ��1 �𝑛∙𝑗 � 22𝑛∙𝑗 + 2��1 − 22𝑛∙𝑗 + 2�� ,�𝑛∙𝑗 � 22𝑛∙𝑗 + 2��1 − 22𝑛∙𝑗 + 2�� , , … , 
 �1 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2�� ,�𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗 + 2��1 − 𝑛∙𝑗2𝑛∙𝑗 + 2��� 
𝐶6 = ��0,�𝑛∙𝑗2 � ,� 2�𝑛∙𝑗 ,�𝑛∙𝑗2 � ,� 4�𝑛∙𝑗 ,�𝑛∙𝑗2 �� 
If �𝑟𝑗1, 𝑟𝑗2� ∈ 𝐶1 then the joint distribution of 𝑟𝑗1 and 𝑟𝑗2 is 
𝑓�𝑟𝑗1, 𝑟𝑗2� = � 2𝑟𝑗1𝑟𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 −�1 − 4𝑟𝑗22 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 − 𝑟𝑗1𝑟𝑗2� ∙ 𝑝𝑗�1−�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1−�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1�. 
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If �𝑟𝑗1, 𝑟𝑗2� ∈ 𝐶2 then the joint distribution of 𝑟𝑗1 and 𝑟𝑗2 is 
𝑓�𝑟𝑗1, 𝑟𝑗2� = � 2𝑟𝑗1𝑟𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 + �1 − 4𝑟𝑗22 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 − 𝑟𝑗1𝑟𝑗2� ∙ 𝑝𝑗�1+�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1+�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1�. 
If �𝑟𝑗1, 𝑟𝑗2� ∈ 𝐶3,𝐶4 or 𝐶5 then the joint distribution of 𝑟𝑗1 and 𝑟𝑗2 is 
𝑓�𝑟𝑗1, 𝑟𝑗2� = � 2𝑟𝑗1𝑟𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 −�1 − 4𝑟𝑗22 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 − 𝑟𝑗1𝑟𝑗2� ∙ 𝑝𝑗�1−�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1−�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1� 
+ � 2𝑟𝑗1𝑟𝑗2� ∙ � 2�𝑛∙𝑗 − 1��1 + �1 − 4𝑟𝑗22 𝑛∙𝑗� � �𝑛∙𝑗 + 1� − 1 − 𝑟𝑗1𝑟𝑗2� ∙ 𝑝𝑗�1+�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1+�1−4𝑟𝑗22 𝑛∙𝑗� ��𝑛∙𝑗+1�. 
If �𝑟𝑗1, 𝑟𝑗2� ∈ 𝐶6 then the joint distribution of 𝑟𝑗1 and 𝑟𝑗2 is 
𝑓�𝑟𝑗1, 𝑟𝑗2� = � 2𝑟𝑗1𝑟𝑗2� ∙ �2�𝑛∙𝑗 − 1�𝑛∙𝑗 − 𝑟𝑗1𝑟𝑗2� ∙ 𝑝𝑗𝑛∙𝑗 ∙ �1 − 𝑝𝑗�𝑛∙𝑗 . 
Now find the marginal distribution of 𝑟𝑗1.  If 𝑟𝑗1 = 0 then  
𝑓1�𝑟𝑗1� = ���2�𝑛∙𝑗 − 1�
𝑡 − 1 � ∙ 𝑝𝑗𝑡−1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−𝑡 + � 2�𝑛∙𝑗 − 1�2𝑛∙𝑗 + 1 − 𝑡� ∙ 𝑝𝑗2𝑛∙𝑗+1−𝑡𝑛∙𝑗
𝑡=3
∙ �1 − 𝑝𝑗�𝑡−1� + ���2�𝑛∙𝑗 − 1�
𝑡 − 1 � ∙ 𝑝𝑗𝑡−1 ∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−𝑡�2
𝑡=1
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+�2�𝑛∙𝑗 − 1�𝑛∙𝑗 � ∙ 𝑝𝑗𝑛∙𝑗 ∙ �1 − 𝑝𝑗�𝑛∙𝑗 
If 𝑟𝑗1 ∈ �2 �𝑛∙𝑗 � 12𝑛∙𝑗+2� �1 − 12𝑛∙𝑗+2�� , 2 �𝑛∙𝑗 � 22𝑛∙𝑗+2� �1 − 22𝑛∙𝑗+2�� � then the distribution of 𝑟𝑗1 
is 
𝑓2�𝑟𝑗1� = � 2�𝑛∙𝑗 − 1�
�1 + �1 − 16 �𝑟𝑗12𝑛∙𝑗�⁄ � �𝑛∙𝑗 + 1� − 3� ∙ 𝑝𝑗�1+�1−16 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1+�1−16 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�. 
If 𝑟𝑗1 ∈ �1 �𝑛∙𝑗 � 22𝑛∙𝑗+2� �1 − 22𝑛∙𝑗+2�� , … , 1 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗+2� �1 − 𝑛∙𝑗2𝑛∙𝑗+2�� � then the distribution of 
𝑟𝑗1 is 
𝑓3�𝑟𝑗1� = 2 ∙ � 2�𝑛∙𝑗 − 1�
�1 −�1 − 4 �𝑟𝑗12𝑛∙𝑗�⁄ � �𝑛∙𝑗 + 1� − 2� ∙ 𝑝𝑗�1−�1−4 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1−�1−4 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1� + 2
∙ �
2�𝑛∙𝑗 − 1�
�1 + �1 − 4 �𝑟𝑗12𝑛∙𝑗�⁄ � �𝑛∙𝑗 + 1� − 2� ∙ 𝑝𝑗�1+�1−4 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1+�1−4 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�. 
If 𝑟𝑗1 ∈ �2 �𝑛∙𝑗 � 32𝑛∙𝑗+2� �1 − 32𝑛∙𝑗+2�� , … , 2 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗+2� �1 − 𝑛∙𝑗2𝑛∙𝑗+2�� � then the distribution of 
𝑟𝑗1 is 
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𝑓4�𝑟𝑗1� = � 2�𝑛∙𝑗 − 1�
�1 −�1 − 16 �𝑟𝑗12𝑛∙𝑗�⁄ � �𝑛∙𝑗 + 1� − 3� ∙ 𝑝𝑗�1−�1−16 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1−�1−16 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�
+ � 2�𝑛∙𝑗 − 1�
�1 + �1 − 16 �𝑟𝑗12𝑛∙𝑗�⁄ � �𝑛∙𝑗 + 1� − 3� ∙ 𝑝𝑗�1+�1−16 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�−1
∙ �1 − 𝑝𝑗�2𝑛∙𝑗+1−�1+�1−16 �𝑟𝑗12 𝑛∙𝑗�� ��𝑛∙𝑗+1�. 
If 𝑟𝑗1 ∈ �2 �𝑛∙𝑗⁄ , 4 �𝑛∙𝑗⁄ � then the distribution of 𝑟𝑗1 is 
𝑓5�𝑟𝑗1� = � 2𝑟𝑗1 ∙ �𝑛∙𝑗 2⁄ �� 2�𝑛∙𝑗 − 1�𝑛∙𝑗 − 𝑟𝑗1 ∙ �𝑛∙𝑗 2⁄ � ∙ 𝑝𝑗𝑛∙𝑗 ∙ �1 − 𝑝𝑗�𝑛∙𝑗 . 
In order to find the distribution of the genetic score the joint distribution of 𝑟11, 𝑟21, …, 𝑟𝐽1 is 
needed.  Since it is assumed that the variants are independent this joint distribution is 
𝑓�𝑟11, 𝑟21, … , 𝑟𝐽1� = �𝑓�𝑟𝑗1�𝐽
𝑗=1
. 
However there are five different formulas for 𝑓�𝑟𝑗1� depending on the value of 𝑟𝑗1.  Hence there 
are 5𝐽 different formulas for the joint distribution of 𝑓�𝑟11, 𝑟21, … , 𝑟𝐽1� depending on the values of 
𝑟11, 𝑟21, … , 𝑟𝐽1.  It is possible to classify these distributions into five different cases.  Let there be 
𝑎1 of the 𝑟𝑗1’s such that 𝑟𝑗1 ∈ �2 �𝑛∙𝑗⁄ , 4 �𝑛∙𝑗⁄ �, 𝑎2 of the 𝑟𝑗1’s such that 
𝑟𝑗1 ∈ �2 �𝑛∙𝑗 � 32𝑛∙𝑗+2� �1 − 32𝑛∙𝑗+2�� , … , 2 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗+2� �1 − 𝑛∙𝑗2𝑛∙𝑗+2�� �, 𝑎3 of the 𝑟𝑗1’s such that 
𝑟𝑗1 ∈ �1 �𝑛∙𝑗 � 22𝑛∙𝑗+2� �1 − 22𝑛∙𝑗+2�� , … , 1 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗+2� �1 − 𝑛∙𝑗2𝑛∙𝑗+2�� �, 𝑎4 of the 𝑟𝑗1’s such that 
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𝑟𝑗1 ∈ �2 �𝑛∙𝑗 � 12𝑛∙𝑗+2� �1 − 12𝑛∙𝑗+2�� , 2 �𝑛∙𝑗 � 22𝑛∙𝑗+2� �1 − 22𝑛∙𝑗+2�� �, and 𝑎5 = 𝐽 − 𝑎1 − 𝑎2 −
𝑎3 − 𝑎4 of the 𝑟𝑗1’s such that 𝑟𝑗1 = 0.  Let 𝑗′ be an index for reordering the 𝑟𝑗1’s such that 
𝑟𝑗′1 ∈ �2 �𝑛∙𝑗⁄ , 4 �𝑛∙𝑗⁄ � for 𝑗′ = 1, … ,𝑎1, 
𝑟𝑗′1 ∈ �2 �𝑛∙𝑗 � 32𝑛∙𝑗+2� �1 − 32𝑛∙𝑗+2�� , … , 2 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗+2� �1 − 𝑛∙𝑗2𝑛∙𝑗+2�� � for 𝑗′ = 𝑎1 + 1, … ,𝑎1 +
𝑎2, 𝑟𝑗′1 ∈ �1 �𝑛∙𝑗 � 22𝑛∙𝑗+2� �1 − 22𝑛∙𝑗+2�� , … , 1 �𝑛∙𝑗 � 𝑛∙𝑗2𝑛∙𝑗+2� �1 − 𝑛∙𝑗2𝑛∙𝑗+2�� � for 𝑗′ = 𝑎1 + 𝑎2 +
1, … ,𝑎1 + 𝑎2 + 𝑎3, 𝑟𝑗′1 ∈ �2 �𝑛∙𝑗 � 12𝑛∙𝑗+2� �1 − 12𝑛∙𝑗+2�� , 2 �𝑛∙𝑗 � 22𝑛∙𝑗+2� �1 − 22𝑛∙𝑗+2�� � for 
𝑗′ = 𝑎1 + 𝑎2 + 𝑎3 + 1, … ,𝑎1 + 𝑎2 + 𝑎3 + 𝑎4, and 𝑟𝑗′1 = 0 for 𝑗′ = 𝑎1 + 𝑎2 + 𝑎3 + 𝑎4 +1, … , 𝐽.  Extending the notation, let 𝑛∙𝑗′  be the number of individuals genotyped for variant j’ and 
𝑝𝑗′  be the probability of a mutant allele at variant j’.  The general form of the joint distribution of 
𝑟11, 𝑟21, …, 𝑟𝐽1 can be rewritten as 
𝑓�𝑟11, 𝑟21, … , 𝑟𝐽1�
= �𝑓5�𝑟𝑗′1�𝑎1
𝑗′=1
∙ � 𝑓4�𝑟𝑗′1�
𝑎1+𝑎2
𝑗′=𝑎1+1
∙ � 𝑓3�𝑟𝑗′1�
𝑎1+𝑎2+𝑎3
𝑗′=𝑎1+𝑎2+1
∙ � 𝑓2�𝑟𝑗′1�
𝑎1+𝑎2+𝑎3+𝑎4
𝑗′=𝑎1+𝑎2+𝑎3+1
∙ � 𝑓1�𝑟𝑗′1�
𝐽
𝑗′=𝑎1+𝑎2+𝑎3+𝑎4+1
. 
Now consider the joint transformation 𝑔1 = ∑ 𝑟𝑗′1𝐽𝑗′=1 , 𝑔2 = 𝑟2′1,𝑔3 = 𝑟3′1, … ,𝑔𝐽 = 𝑟𝐽′1.  
Clearly the formulas for most of the variables will be similar since all but one of the 𝑟𝑗′1’s is 
directly transformed to a 𝑔𝑗′ .  However 𝑟1′1 = 𝑔1 − ∑ 𝑟𝑗′1𝐽𝑗′=2  thus the distribution of 𝑟1′1 must 
be considered when finding the joint distribution of 𝑔1,𝑔2, … ,𝑔𝐽.  First consider a case 1 where at 
least one 𝑟𝑗′1 ∈ �2 �𝑛∙𝑗⁄ , 4 �𝑛∙𝑗⁄ �.  Then the joint distribution of 𝑔1,𝑔2, … ,𝑔𝐽 is 
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𝑓�𝑔1,𝑔2, … ,𝑔𝐽�
= � 2�√𝑛∙1′2 ��𝑔1 −� 𝑔𝑗′𝐽𝑗′=2 ���
2(𝑛∙1′ − 1)
𝑛∙1′ − �
√𝑛∙1′2 ��𝑔1 −� 𝑔𝑗′𝐽𝑗′=2 �� ∙ 𝑝1′𝑛∙1′
∙ (1 − 𝑝1′)𝑛∙1′ ∙� 𝑓5�𝑟𝑗′1 = 𝑔𝑗′�𝑎1
𝑗′=2
∙ � 𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2
𝑗′=𝑎1+1
∙ � 𝑓3�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2+𝑎3
𝑗′=𝑎1+𝑎2+1
∙ � 𝑓2�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2+𝑎3+𝑎4
𝑗′=𝑎1+𝑎2+𝑎3+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎1+𝑎2+𝑎3+𝑎4+1
 
where 𝑔1 − ∑ 𝑔𝑗′
𝐽
𝑗′=2 ∈ {2 √𝑛∙1′⁄ , 4 √𝑛∙1′⁄ }.  Now sum over 𝑔𝑎1+𝑎2+𝑎3+𝑎4+1, … ,𝑔𝐽.  Since each 
of these values is zero and the 𝑓1�𝑔𝑗′�’s are constants the joint distribution of 
𝑔1, … ,𝑔𝑎1+𝑎2+𝑎3+𝑎4 is 
𝑓�𝑔1,𝑔2, … ,𝑔𝑎1+𝑎2+𝑎3+𝑎4�
= � 2�√𝑛∙1′2 ��𝑔1 −� 𝑔𝑗′𝑎1+𝑎2+𝑎3+𝑎4𝑗′=2 ���
2(𝑛∙1′ − 1)
𝑛∙1′ − �
√𝑛∙1′2 ��𝑔1 −� 𝑔𝑗′𝑎1+𝑎2+𝑎3+𝑎4𝑗′=2 �� ∙ 𝑝1′𝑛∙1′
∙ (1 − 𝑝1′)𝑛∙1′ ∙� 𝑓5�𝑟𝑗′1 = 𝑔𝑗′�𝑎1
𝑗′=2
∙ � 𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2
𝑗′=𝑎1+1
∙ � 𝑓3�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2+𝑎3
𝑗′=𝑎1+𝑎2+1
∙ � 𝑓2�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2+𝑎3+𝑎4
𝑗′=𝑎1+𝑎2+𝑎3+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎1+𝑎2+𝑎3+𝑎4+1
 
where 𝑔1 − ∑ 𝑔𝑗′
𝑎1+𝑎2+𝑎3+𝑎4
𝑗′=2 ∈ {2 √𝑛∙1′⁄ , 4 √𝑛∙1′⁄ }.  Now sum over 
𝑔𝑎1+𝑎2+𝑎3+1, … ,𝑔𝑎1+𝑎2+𝑎3+𝑎4.  Let 
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𝑑𝑖𝑓𝑓1 = 𝑔1 − ∑ 𝑔𝑗′𝑎1+𝑎2+𝑎3𝑗′=2 − ∑ 2
�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2�
𝑎4
𝑖=1  for 
𝑢𝑖 ∈ {1, 2}.  Then the joint distribution of 𝑔1, … ,𝑔𝑎1+𝑎2+𝑎3 is 
𝑓�𝑔1,𝑔2, … ,𝑔𝑎1+𝑎2+𝑎3�
= 𝑝
1′
𝑛∙1′ ∙ (1 − 𝑝1′)𝑛∙1′ ∙� 𝑓5�𝑟𝑗′1 = 𝑔𝑗′�𝑎1
𝑗′=2
∙ � 𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2
𝑗′=𝑎1+1
∙ � 𝑓3�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2+𝑎3
𝑗′=𝑎1+𝑎2+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎1+𝑎2+𝑎3+𝑎4+1
 
∙ � � … � ���� 2�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1�2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+1−𝑢𝑖𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
∙ �1 − 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′�𝑢𝑖−1� 
∙ �
2
�
√𝑛∙1′2 � (𝑑𝑖𝑓𝑓1)� ∙ � 2(𝑛∙1′ − 1)𝑛∙1′ − �√𝑛∙1′2 � (𝑑𝑖𝑓𝑓1)��� 
where 𝑑𝑖𝑓𝑓1 ∈ {2 √𝑛∙1′⁄ , 4 √𝑛∙1′⁄ }.  Now sum over 𝑔𝑎1+𝑎2+1, … ,𝑔𝑎1+𝑎2+𝑎3.  Let 𝑑𝑖𝑓𝑓2 = 𝑔1 −
∑ 𝑔𝑗′
𝑎1+𝑎2
𝑗′=2 − ∑
2
�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2�
𝑎4
𝑖=1  
−∑
1
�𝑛∙(𝑎1+𝑎2+𝑑)′� 𝑣𝑑2𝑛∙(𝑎1+𝑎2+𝑑)′+2��1− 𝑣𝑑2𝑛∙(𝑎1+𝑎2+𝑑)′+2�
𝑎3
𝑑=1  where 𝑢𝑖 ∈ {1, 2} and 
𝑣𝑑 ∈ �2, … ,𝑛∙(𝑎1+𝑎2+𝑑)′�.  The joint distribution of 𝑔1, … ,𝑔𝑎1+𝑎2 is 
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𝑓�𝑔1,𝑔2, … ,𝑔𝑎1+𝑎2�
= 𝑝
1′
𝑛∙1′ ∙ (1 − 𝑝1′)𝑛∙1′ ∙� 𝑓5�𝑟𝑗′1 = 𝑔𝑗′�𝑎1
𝑗′=2
∙ � 𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎1+𝑎2
𝑗′=𝑎1+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎1+𝑎2+𝑎3+𝑎4+1
 
∙ � � … � ���2�2�𝑛∙(𝑎1+𝑎2+𝑑)′ − 1�
𝑣𝑑 − 2 � ∙ 𝑝(𝑎1+𝑎2+𝑑)′𝑣𝑑−1𝑎3𝑑=1
𝑛∙(𝑎1+𝑎2+1)′
𝑣1=2
𝑛∙(𝑎1+𝑎2+𝑎3)′
𝑣𝑎3=2
 
∙ �1 − 𝑝(𝑎1+𝑎2+𝑑)′�2𝑛∙(𝑎1+𝑎2+𝑑)′+1−𝑣𝑑 
+2�2�𝑛∙(𝑎1+𝑎2+𝑑)′ − 1�2𝑛∙(𝑎1+𝑎2+𝑑)′ − 𝑣𝑑 � 𝑝(𝑎1+𝑎2+𝑑)′2𝑛∙(𝑎1+𝑎2+𝑑)′+1−𝑣𝑑�1 − 𝑝(𝑎1+𝑎2+𝑑)′�𝑣𝑑−1� 
� … � ���� 2�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1�2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+1−𝑢𝑖𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
∙ �1 − 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′�𝑢𝑖−1� 
∙ �
2
�
√𝑛∙1′2 � (𝑑𝑖𝑓𝑓2)� ∙ � 2(𝑛∙1′ − 1)𝑛∙1′ − �√𝑛∙1′2 � (𝑑𝑖𝑓𝑓2)���� 
where 𝑑𝑖𝑓𝑓2 ∈ {2 √𝑛∙1′⁄ , 4 √𝑛∙1′⁄ }.  Now sum over 𝑔𝑎1+1, … ,𝑔𝑎1+𝑎2.  Let 𝑑𝑖𝑓𝑓3 = 𝑔1 −
∑ 𝑔𝑗′
𝑎1
𝑗′=2 − ∑
2
�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2�
𝑎4
𝑖=1 −
∑ 1
�𝑛∙(𝑎1+𝑎2+𝑑)′� 𝑣𝑑2𝑛∙(𝑎1+𝑎2+𝑑)′+2��1− 𝑣𝑑2𝑛∙(𝑎1+𝑎2+𝑑)′+2�
𝑎3
𝑑=1 − ∑
2
�𝑛∙(𝑎1+𝑒)′� 𝑥𝑒2𝑛∙(𝑎1+𝑒)′+2��1− 𝑥𝑒2𝑛∙(𝑎1+𝑒)′+2�
𝑎2
𝑒=1  
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where 𝑢𝑖 ∈ {1, 2}, 𝑣𝑑 ∈ �2, … ,𝑛∙(𝑎1+𝑎2+𝑑)′�, and 𝑥𝑒 ∈ �3, … ,𝑛∙(𝑎1+𝑒)′�.  Then the joint 
distribution of 𝑔1, … ,𝑔𝑎1 is 
𝑓�𝑔1,𝑔2, … ,𝑔𝑎1� = 𝑝1′𝑛∙1′ ∙ (1 − 𝑝1′)𝑛∙1′ ∙� 𝑓5�𝑟𝑗′1 = 𝑔𝑗′�𝑎1
𝑗′=2
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎1+𝑎2+𝑎3+𝑎4+1
 
∙ � � … � ����2�𝑛∙(𝑎1+𝑒)′ − 1�
𝑥𝑒 − 3 �𝑝(𝑎1+𝑒)′𝑥𝑒−1 �1 − 𝑝(𝑎1+𝑒)′�2𝑛∙(𝑎1+𝑒)′+1−𝑥𝑒𝑎2𝑒=1
𝑛𝑎1+1
𝑥1=3
𝑛𝑎1+𝑎2
𝑥𝑎2=3
+ � 2�𝑛∙(𝑎1+𝑒)′ − 1�2𝑛∙(𝑎1+𝑒)′ − 𝑥𝑒 − 1�𝑝(𝑎1+𝑒)′2𝑛∙(𝑎1+𝑒)′+1−𝑥𝑒�1 − 𝑝(𝑎1+𝑒)′�𝑥𝑒−1� 
∙ � … � ���2 �2�𝑛∙(𝑎1+𝑎2+𝑑)′ − 1�
𝑣𝑑 − 2 � ∙ 𝑝(𝑎1+𝑎2+𝑑)′𝑣𝑑−1𝑎3𝑑=1
𝑛∙(𝑎1+𝑎2+1)′
𝑣1=2
𝑛∙(𝑎1+𝑎2+𝑎3)′
𝑣𝑎3=2
 
∙ �1 − 𝑝(𝑎1+𝑎2+𝑑)′�2𝑛∙(𝑎1+𝑎2+𝑑)′+1−𝑣𝑑 
+2�2�𝑛∙(𝑎1+𝑎2+𝑑)′ − 1�2𝑛∙(𝑎1+𝑎2+𝑑)′ − 𝑣𝑑 � 𝑝(𝑎1+𝑎2+𝑑)′2𝑛∙(𝑎1+𝑎2+𝑑)′+1−𝑣𝑑�1 − 𝑝(𝑎1+𝑎2+𝑑)′�𝑣𝑑−1� 
� … � ���� 2�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1�2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+1−𝑢𝑖𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
∙ �1 − 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′�𝑢𝑖−1� 
∙ �
2
�
√𝑛∙1′2 � (𝑑𝑖𝑓𝑓3)� ∙ � 2(𝑛∙1′ − 1)𝑛∙1′ − �√𝑛∙1′2 � (𝑑𝑖𝑓𝑓3)���
⎭
⎪
⎬
⎪
⎫
⎦
⎥
⎥
⎥
⎤
 
where 𝑑𝑖𝑓𝑓3 ∈ {2 √𝑛∙1′⁄ , 4 √𝑛∙1′⁄ }.  Now sum over 𝑔2, … ,𝑔𝑎1.  Let 
𝑑𝑖𝑓𝑓4 =
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𝑔1 − ∑
2
�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+2�
𝑎4
𝑖=1 −
∑ 1
�𝑛∙(𝑎1+𝑎2+𝑑)′� 𝑣𝑑2𝑛∙(𝑎1+𝑎2+𝑑)′+2��1− 𝑣𝑑2𝑛∙(𝑎1+𝑎2+𝑑)′+2�
𝑎3
𝑑=1 − ∑
2
�𝑛∙(𝑎1+𝑒)′� 𝑥𝑒2𝑛∙(𝑎1+𝑒)′+2��1− 𝑥𝑒2𝑛∙(𝑎1+𝑒)′+2�
𝑎2
𝑒=1 −
∑ 2𝑠ℎ
�𝑛∙ℎ′
𝑎1
ℎ=2  where 𝑢𝑖 ∈ {1, 2}, 𝑣𝑑 ∈ �2, … ,𝑛∙(𝑎1+𝑎2+𝑑)′�, 𝑥𝑒 ∈ �3, … ,𝑛∙(𝑎1+𝑒)′�, and 𝑠ℎ ∈ {1, 2}.  
Then the distribution of 𝑔1, the genetic score, for this case is 
𝑓(𝑔1) = 𝑝1′𝑛∙1′ ∙ (1 − 𝑝1′)𝑛∙1′ ∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎1+𝑎2+𝑎3+𝑎4+1
 
∙ � � … � ���� 2𝑠ℎ� �2(𝑛∙ℎ′ − 1)𝑛∙ℎ′ − 𝑠ℎ � 𝑝ℎ′𝑛∙ℎ′(1 − 𝑝ℎ′)𝑛∙ℎ′�𝑎1
ℎ=2
2
𝑠2=1
2
𝑠𝑎1=1
 
� … � ����2�𝑛∙(𝑎1+𝑒)′ − 1�
𝑥𝑒 − 3 �𝑝(𝑎1+𝑒)′𝑥𝑒−1 �1 − 𝑝(𝑎1+𝑒)′�2𝑛∙(𝑎1+𝑒)′+1−𝑥𝑒𝑎2𝑒=1
𝑛𝑎1+1
𝑥1=3
𝑛𝑎1+𝑎2
𝑥𝑎2=3
+ � 2�𝑛∙(𝑎1+𝑒)′ − 1�2𝑛∙(𝑎1+𝑒)′ − 𝑥𝑒 − 1�𝑝(𝑎1+𝑒)′2𝑛∙(𝑎1+𝑒)′+1−𝑥𝑒�1 − 𝑝(𝑎1+𝑒)′�𝑥𝑒−1� 
∙ � … � ���2 �2�𝑛∙(𝑎1+𝑎2+𝑑)′ − 1�
𝑣𝑑 − 2 � ∙ 𝑝(𝑎1+𝑎2+𝑑)′𝑣𝑑−1𝑎3𝑑=1
𝑛∙(𝑎1+𝑎2+1)′
𝑣1=2
𝑛∙(𝑎1+𝑎2+𝑎3)′
𝑣𝑎3=2
 
∙ �1 − 𝑝(𝑎1+𝑎2+𝑑)′�2𝑛∙(𝑎1+𝑎2+𝑑)′+1−𝑣𝑑 
+2�2�𝑛∙(𝑎1+𝑎2+𝑑)′ − 1�2𝑛∙(𝑎1+𝑎2+𝑑)′ − 𝑣𝑑 � 𝑝(𝑎1+𝑎2+𝑑)′2𝑛∙(𝑎1+𝑎2+𝑑)′+1−𝑣𝑑�1 − 𝑝(𝑎1+𝑎2+𝑑)′�𝑣𝑑−1� 
33 
 
∙ � … � ���� 2�𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1�2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′2𝑛∙(𝑎1+𝑎2+𝑎3+𝑖)′+1−𝑢𝑖𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
∙ �1 − 𝑝(𝑎1+𝑎2+𝑎3+𝑖)′�𝑢𝑖−1� 
∙ �
2
�
√𝑛∙1′2 � (𝑑𝑖𝑓𝑓4)� ∙ � 2(𝑛∙1′ − 1)𝑛∙1′ − �√𝑛∙1′2 � (𝑑𝑖𝑓𝑓4)���
⎭
⎪
⎬
⎪
⎫
⎭
⎪
⎬
⎪
⎫
⎦
⎥
⎥
⎥
⎤
 
where 𝑑𝑖𝑓𝑓4 ∈ {2 √𝑛∙1′⁄ , 4 √𝑛∙1′⁄ }. 
 Now consider a second case where 𝑎1 = 0 and 𝑎2 > 0.  Then 
𝑟1′1 ∈ �2 �𝑛∙1′ � 32𝑛∙1′+2� �1 − 32𝑛∙1′+2�� , … , 2 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  Transforming to 
𝑔1,𝑔2, … ,𝑔𝐽 gives 
𝑓�𝑔1,𝑔2, … ,𝑔𝐽�
= �𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎2
𝑗′=2
∙ � 𝑓3�𝑟𝑗′1 = 𝑔𝑗′�𝑎2+𝑎3
𝑗′=𝑎2+1
∙ � 𝑓2�𝑟𝑗′1 = 𝑔𝑗′�𝑎2+𝑎3+𝑎4
𝑗′=𝑎2+𝑎3+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎2+𝑎3+𝑎4+1
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∙
⎣
⎢
⎢
⎢
⎡
⎝
⎜
⎛
2(𝑛∙1′ − 1)
�1 −�1 − 16 �𝑛∙1′ �𝑔1 −� 𝑔𝑗′𝐽
𝑗′=2
�
2
�� � (𝑛∙1′ + 1) − 3
⎠
⎟
⎞
∙ 𝑝
1′
�1−�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′
𝐽
𝑗′=2
�
2
�� ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′𝐽𝑗′=2 �2�� ��𝑛∙1′+1�
+
⎝
⎜
⎛
2(𝑛∙1′ − 1)
�1 + �1 − 16 �𝑛∙1′ �𝑔1 −� 𝑔𝑗′𝐽
𝑗′=2
�
2
�� � (𝑛∙1′ + 1) − 3
⎠
⎟
⎞
∙ 𝑝
1′
�1+�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′
𝐽
𝑗′=2
�
2
�� ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′𝐽𝑗′=2 �2�� ��𝑛∙1′+1�
⎦
⎥
⎥
⎥
⎤
 
where 𝑔1 − ∑ 𝑔𝑗′
𝐽
𝑗′=2 ∈ �2 �𝑛∙1′ � 32𝑛∙1′+2� �1 − 32𝑛∙1′+2�� , … , 2 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  
Now sum over 𝑔𝑎2+𝑎3+𝑎4+1, … ,𝑔𝐽.   These variables are all equal to zero and 𝑓1�𝑔𝑗′� is a 
constant so 
𝑓�𝑔1,𝑔2, … ,𝑔𝑎2+𝑎3+𝑎4�
= �𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎2
𝑗′=2
∙ � 𝑓3�𝑟𝑗′1 = 𝑔𝑗′�𝑎2+𝑎3
𝑗′=𝑎2+1
∙ � 𝑓2�𝑟𝑗′1 = 𝑔𝑗′�𝑎2+𝑎3+𝑎4
𝑗′=𝑎2+𝑎3+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎2+𝑎3+𝑎4+1
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∙
⎣
⎢
⎢
⎢
⎡
⎝
⎜
⎛
2(𝑛∙1′ − 1)
�1 −�1 − 16 �𝑛∙1′ �𝑔1 −� 𝑔𝑗′𝑎2+𝑎3+𝑎4
𝑗′=2
�
2
�� � (𝑛∙1′ + 1) − 3
⎠
⎟
⎞
∙ 𝑝
1′
�1−�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′
𝑎2+𝑎3+𝑎4
𝑗′=2
�
2
�� ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′𝑎2+𝑎3+𝑎4𝑗′=2 �2�� ��𝑛∙1′+1�
+
⎝
⎜
⎛
2(𝑛∙1′ − 1)
�1 + �1 − 16 �𝑛∙1′ �𝑔1 −� 𝑔𝑗′𝑎2+𝑎3+𝑎4
𝑗′=2
�
2
�� � (𝑛∙1′ + 1) − 3
⎠
⎟
⎞
∙ 𝑝
1′
�1+�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′
𝑎2+𝑎3+𝑎4
𝑗′=2
�
2
�� ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′𝑎2+𝑎3+𝑎4𝑗′=2 �2�� ��𝑛∙1′+1�
⎦
⎥
⎥
⎥
⎤
 
where 
𝑔1 − ∑ 𝑔𝑗′
𝑎2+𝑎3+𝑎4
𝑗′=2 ∈ �2 �𝑛∙1′ � 32𝑛∙1′+2� �1 − 32𝑛∙1′+2�� , … , 2 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �. 
Now sum over 𝑔𝑎2+𝑎3+1, … ,𝑔𝑎2+𝑎3+𝑎4.  Let 
𝑑𝑖𝑓𝑓5 = 𝑔1 − ∑ 𝑔𝑗′𝑎2+𝑎3𝑗′=2 − ∑ 2
�𝑛∙(𝑎2+𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎2+𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎2+𝑎3+𝑖)′+2�
𝑎4
𝑖=1  where 𝑢𝑖 ∈ {1, 2}.  
Then the joint distribution of 𝑔1,𝑔2, … ,𝑔𝑎2+𝑎3 is 
36 
 
𝑓�𝑔1,𝑔2, … ,𝑔𝑎2+𝑎3�
= �𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎2
𝑗′=2
∙ � 𝑓3�𝑟𝑗′1 = 𝑔𝑗′�𝑎2+𝑎3
𝑗′=𝑎2+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎2+𝑎3+𝑎4+1
 
∙ � � … � ���� 2�𝑛∙(𝑎2+𝑎3+𝑖)′ − 1�2𝑛∙(𝑎2+𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎2+𝑎3+𝑖)′2𝑛∙(𝑎2+𝑎3+𝑖)′+1−𝑢𝑖 ∙ �1 − 𝑝(𝑎2+𝑎3+𝑖)′�𝑢𝑖−1�𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
 
��
2(𝑛∙1′ − 1)
�1 −�1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓5)2)⁄ � (𝑛∙1′ + 1) − 3� ∙ 𝑝1′�1−�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓5)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓5)2�⁄ ��𝑛∙1′+1� 
+� 2(𝑛∙1′ − 1)
�1 + �1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓5)2)⁄ � (𝑛∙1′ + 1) − 3� ∙ 𝑝1′�1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓5)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓5)2�⁄ ��𝑛∙1′+1���� 
where 𝑑𝑖𝑓𝑓5 ∈ �2 �𝑛∙1′ � 32𝑛∙1′+2� �1 − 32𝑛∙1′+2�� , … , 2 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  Now sum 
over 𝑔𝑎2+1, … ,𝑔𝑎2+𝑎3.  Let 
𝑑𝑖𝑓𝑓6 =
𝑔1 − ∑ 𝑔𝑗′
𝑎2
𝑗′=2 − ∑
2
�𝑛∙(𝑎2+𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎2+𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎2+𝑎3+𝑖)′+2�
𝑎4
𝑖=1 −
∑ 1
�𝑛∙(𝑎2+𝑑)′� 𝑣𝑑2𝑛∙(𝑎2+𝑑)′+2��1− 𝑣𝑑2𝑛∙(𝑎2+𝑑)′+2�
𝑎3
𝑑=1  where 𝑢𝑖 ∈ {1, 2} and 𝑣𝑑 ∈ �2, … ,𝑛∙(𝑎2+𝑑)′�.  Then the 
joint distribution of  𝑔1, … ,𝑔𝑎2 is 
37 
 
𝑓�𝑔1, … ,𝑔𝑎2� = �𝑓4�𝑟𝑗′1 = 𝑔𝑗′�𝑎2
𝑗′=2
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎2+𝑎3+𝑎4+1
 
∙ � � … � ���2�2�𝑛∙(𝑎2+𝑑)′ − 1�
𝑣𝑑 − 2 � ∙ 𝑝(𝑎2+𝑑)′𝑣𝑑−1𝑎3𝑑=1
𝑛∙(𝑎1+𝑎2+1)′
𝑣1=2
𝑛∙(𝑎1+𝑎2+𝑎3)′
𝑣𝑎3=2
∙ �1 − 𝑝(𝑎2+𝑑)′�2𝑛∙(𝑎2+𝑑)′+1−𝑣𝑑 
+2�2�𝑛∙(𝑎2+𝑑)′ − 1�2𝑛∙(𝑎2+𝑑)′ − 𝑣𝑑 � 𝑝(𝑎2+𝑑)′2𝑛∙(𝑎2+𝑑)′+1−𝑣𝑑�1 − 𝑝(𝑎2+𝑑)′�𝑣𝑑−1� 
� … � ���� 2�𝑛∙(𝑎2+𝑎3+𝑖)′ − 1�2𝑛∙(𝑎2+𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎2+𝑎3+𝑖)′2𝑛∙(𝑎2+𝑎3+𝑖)′+1−𝑢𝑖 ∙ �1 − 𝑝(𝑎2+𝑎3+𝑖)′�𝑢𝑖−1�𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
 
��
2(𝑛∙1′ − 1)
�1 −�1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓6)2)⁄ � (𝑛∙1′ + 1) − 3� ∙ 𝑝1′�1−�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓6)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓6)2�⁄ ��𝑛∙1′+1� 
+� 2(𝑛∙1′ − 1)
�1 + �1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓6)2)⁄ � (𝑛∙1′ + 1) − 3� ∙ 𝑝1′�1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓6)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓6)2�⁄ ��𝑛∙1′+1����� 
where 𝑑𝑖𝑓𝑓6 ∈ �2 �𝑛∙1′ � 32𝑛∙1′+2� �1 − 32𝑛∙1′+2�� , … , 2 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  Now sum 
over 𝑔2, … ,𝑔𝑎2.  Let 𝑑𝑖𝑓𝑓7 = 𝑔1 − ∑ 2
�𝑛∙(𝑎2+𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎2+𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎2+𝑎3+𝑖)′+2�
𝑎4
𝑖=1 −
∑ 1
�𝑛∙(𝑎2+𝑑)′� 𝑣𝑑2𝑛∙(𝑎2+𝑑)′+2��1− 𝑣𝑑2𝑛∙(𝑎2+𝑑)′+2�
𝑎3
𝑑=1 − ∑
2
�𝑛∙𝑒′�
𝑥𝑒
2𝑛∙𝑒′+2
��1−
𝑥𝑒
2𝑛∙𝑒′+2
�
𝑎2
𝑒=2  where 𝑢𝑖 ∈ {1, 2}, 
38 
 
𝑣𝑑 ∈ �2, … ,𝑛∙(𝑎2+𝑑)′�, and 𝑥𝑒 ∈ {3, … ,𝑛∙𝑒′}.  Then the distribution of the genetic score, 𝑔1, for 
this case is 
𝑓(𝑔1) = � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎2+𝑎3+𝑎4+1
 
∙ � � … � ����2(𝑛∙𝑒′ − 1)
𝑥𝑒 − 3 � 𝑝𝑒′𝑥𝑒−1(1 − 𝑝𝑒′)2𝑛∙𝑒′+1−𝑥𝑒𝑎2
𝑒=2
𝑛2
𝑥2=3
𝑛𝑎2
𝑥𝑎2=3 + � 2(𝑛∙𝑒′ − 1)2𝑛∙𝑒′ − 𝑥𝑒 − 1� 𝑝𝑒′2𝑛∙𝑒′+1−𝑥𝑒(1 − 𝑝𝑒′)𝑥𝑒−1� 
� … � ���2 �2�𝑛∙(𝑎2+𝑑)′ − 1�
𝑣𝑑 − 2 � ∙ 𝑝(𝑎2+𝑑)′𝑣𝑑−1𝑎3𝑑=1
𝑛∙(𝑎1+𝑎2+1)′
𝑣1=2
𝑛∙(𝑎1+𝑎2+𝑎3)′
𝑣𝑎3=2
∙ �1 − 𝑝(𝑎2+𝑑)′�2𝑛∙(𝑎2+𝑑)′+1−𝑣𝑑 
+2�2�𝑛∙(𝑎2+𝑑)′ − 1�2𝑛∙(𝑎2+𝑑)′ − 𝑣𝑑 � 𝑝(𝑎2+𝑑)′2𝑛∙(𝑎2+𝑑)′+1−𝑣𝑑�1 − 𝑝(𝑎2+𝑑)′�𝑣𝑑−1� 
∙ � … � ���� 2�𝑛∙(𝑎2+𝑎3+𝑖)′ − 1�2𝑛∙(𝑎2+𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎2+𝑎3+𝑖)′2𝑛∙(𝑎2+𝑎3+𝑖)′+1−𝑢𝑖 ∙ �1 − 𝑝(𝑎2+𝑎3+𝑖)′�𝑢𝑖−1�𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
 
��
2(𝑛∙1′ − 1)
�1 −�1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓7)2)⁄ � (𝑛∙1′ + 1) − 3� ∙ 𝑝1′�1−�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓7)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓7)2�⁄ ��𝑛∙1′+1� 
+� 2(𝑛∙1′ − 1)
�1 + �1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓7)2)⁄ � (𝑛∙1′ + 1) − 3� ∙ 𝑝1′�1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓7)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓7)2�⁄ ��𝑛∙1′+1����
⎭
⎪
⎬
⎪
⎫
⎦
⎥
⎥
⎥
⎤
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where 𝑑𝑖𝑓𝑓7 ∈ �2 �𝑛∙1′ � 32𝑛∙1′+2� �1 − 32𝑛∙1′+2�� , … , 2 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �. 
 Next consider case 3 where 𝑎1 = 𝑎2 = 0 and 𝑎3 > 0.  In this case 
𝑟1′1 ∈ �1 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� , … , 1 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  Thus the joint 
distribution of 𝑔1,𝑔2, … ,𝑔𝐽 is 
𝑓�𝑔1,𝑔2, … ,𝑔𝐽� = �𝑓3�𝑟𝑗′1 = 𝑔𝑗′�𝑎3
𝑗′=3
∙ � 𝑓2�𝑟𝑗′1 = 𝑔𝑗′�𝑎3+𝑎4
𝑗′=𝑎3+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎3+𝑎4+1
 
∙
⎣
⎢
⎢
⎢
⎡2 ∙
⎝
⎜
⎛
2(𝑛∙1′ − 1)
�1 −�1 − 4 �𝑛∙1′ �𝑔1 −� 𝑔𝑗′𝐽
𝑗′=2
�
2
�� � (𝑛∙1′ + 1) − 2
⎠
⎟
⎞
∙ 𝑝
1′
�1−�1−4 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′
𝐽
𝑗′=2
�
2
�� ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−4 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′𝐽𝑗′=2 �2�� ��𝑛∙1′+1� 
+
⎝
⎜
⎛
2(𝑛∙1′ − 1)
�1 + �1 − 4 �𝑛∙1′ �𝑔1 −� 𝑔𝑗′𝐽
𝑗′=2
�
2
�� � (𝑛∙1′ + 1) − 2
⎠
⎟
⎞
∙ 𝑝
1′
�1+�1−4 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′
𝐽
𝑗′=2
�
2
�� ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−4 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′𝐽𝑗′=2 �2�� ��𝑛∙1′+1�
⎦
⎥
⎥
⎥
⎤
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where 𝑔1 − ∑ 𝑔𝑗′
𝐽
𝑗′=2 ∈ �1 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� , … , 1 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  
Now sum out 𝑔2, … ,𝑔𝑎3.  Let 𝑑𝑖𝑓𝑓8 = 𝑔1 − ∑ 𝑔𝑗′𝐽𝑗′=𝑎3+1 − ∑ 1
�𝑛∙𝑑′�
𝑣𝑑
2𝑛∙𝑑′+2
��1−
𝑣𝑑
2𝑛∙𝑑′+2
�
𝑎3
𝑑=2  where 
𝑣𝑑 ∈ {2, … ,𝑛∙𝑑′}.  Then the joint distribution of 𝑔1,𝑔𝑎3+1, … ,𝑔𝐽 is 
𝑓�𝑔1,𝑔𝑎3+1, … ,𝑔𝐽� = � 𝑓2�𝑟𝑗′1 = 𝑔𝑗′�𝑎3+𝑎4
𝑗′=𝑎3+1
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎3+𝑎4+1
 
∙ � � … � ���2 �2(𝑛∙𝑑′ − 1)
𝑣𝑑 − 2 � 𝑝𝑑′𝑣𝑑−1(1 − 𝑝𝑑′)2𝑛∙𝑑′+1−𝑣𝑑𝑎3
𝑑=2
𝑛2
𝑣2=2
𝑛𝑎3
𝑣𝑎3=2 + 2 �2(𝑛∙𝑑′ − 1)2𝑛∙𝑑′ − 𝑣𝑑 � 𝑝𝑑′2𝑛∙𝑑′+1−𝑣𝑑(1 − 𝑝𝑑′)𝑣𝑑−1� 
∙ �2 ∙ � 2(𝑛∙1′ − 1)
�1 −�1 − 4 (𝑛∙1′(𝑑𝑖𝑓𝑓8)2)⁄ � (𝑛∙1′ + 1) − 2� ∙ 𝑝1′�1−�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓8)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓8)2�⁄ ��𝑛∙1′+1� 
+� 2(𝑛∙1′ − 1)
�1 + �1 − 4 (𝑛∙1′(𝑑𝑖𝑓𝑓8)2)⁄ � (𝑛∙1′ + 1) − 2� ∙ 𝑝1′�1+�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓8)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓8)2�⁄ ��𝑛∙1′+1���� 
where 𝑑𝑖𝑓𝑓8 ∈ �1 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� , … , 1 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  Now sum 
over 𝑔𝑎3+1, … ,𝑔𝑎3+𝑎4.  Let 𝑑𝑖𝑓𝑓9 = 𝑔1 − ∑ 𝑔𝑗′𝐽𝑗′=𝑎3+𝑎4+1 − ∑ 1
�𝑛∙𝑑′�
𝑣𝑑
2𝑛∙𝑑′+2
��1−
𝑣𝑑
2𝑛∙𝑑′+2
�
𝑎3
𝑑=2 −
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∑ 2
�𝑛∙(𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎3+𝑖)′+2�
𝑎4
𝑖=1  where 𝑢𝑖 ∈ {1, 2} and 𝑣𝑑 ∈ {2, … ,𝑛∙𝑑′}.  The joint 
distribution of 𝑔1,𝑔𝑎3+𝑎4+1, … ,𝑔𝐽 is 
𝑓�𝑔1,𝑔𝑎3+1, … ,𝑔𝐽� = � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎3+𝑎4+1
 
∙ � � … � ���� 2�𝑛∙(𝑎3+𝑖)′ − 1�2𝑛∙(𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎3+𝑖)′2𝑛∙(𝑎3+𝑖)′+1−𝑢𝑖 ∙ �1 − 𝑝(𝑎3+𝑖)′�𝑢𝑖−1�𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
 
� … � ���2 �2(𝑛∙𝑑′ − 1)
𝑣𝑑 − 2 � 𝑝𝑑′𝑣𝑑−1(1 − 𝑝𝑑′)2𝑛∙𝑑′+1−𝑣𝑑𝑎3
𝑑=2
𝑛2
𝑣2=2
𝑛𝑎3
𝑣𝑎3=2 + 2 �2(𝑛∙𝑑′ − 1)2𝑛∙𝑑′ − 𝑣𝑑 �𝑝𝑑′2𝑛∙𝑑′+1−𝑣𝑑(1 − 𝑝𝑑′)𝑣𝑑−1� 
∙ �2 ∙ � 2(𝑛∙1′ − 1)
�1 −�1 − 4 (𝑛∙1′(𝑑𝑖𝑓𝑓9)2)⁄ � (𝑛∙1′ + 1) − 2� ∙ 𝑝1′�1−�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓9)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓9)2�⁄ ��𝑛∙1′+1� 
+� 2(𝑛∙1′ − 1)
�1 + �1 − 4 (𝑛∙1′(𝑑𝑖𝑓𝑓9)2)⁄ � (𝑛∙1′ + 1) − 2� ∙ 𝑝1′�1+�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓9)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓9)2�⁄ ��𝑛∙1′+1���� 
where 𝑑𝑖𝑓𝑓9 ∈ �1 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� , … , 1 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �.  Now sum 
over 𝑔𝑎3+𝑎4+1, … ,𝑔𝐽.  These variables are all equal to zero and the 𝑓1�𝑔𝑗′�’s are all constants.  
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Let 𝑑𝑖𝑓𝑓10 = 𝑔1 − ∑ 1
�𝑛∙𝑑′�
𝑣𝑑
2𝑛∙𝑑′+2
��1−
𝑣𝑑
2𝑛∙𝑑′+2
�
𝑎3
𝑑=2 − ∑
2
�𝑛∙(𝑎3+𝑖)′� 𝑢𝑖2𝑛∙(𝑎3+𝑖)′+2��1− 𝑢𝑖2𝑛∙(𝑎3+𝑖)′+2�
𝑎4
𝑖=1  
where 𝑢𝑖 ∈ {1, 2} and 𝑣𝑑 ∈ {2, … ,𝑛∙𝑑′}.  Thus the distribution of the genetic score, 𝑔1, for this 
case is 
𝑓(𝑔1) = � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎3+𝑎4+1
 
∙ � � … � ���� 2�𝑛∙(𝑎3+𝑖)′ − 1�2𝑛∙(𝑎3+𝑖)′ − 1 − 𝑢𝑖� ∙ 𝑝(𝑎3+𝑖)′2𝑛∙(𝑎3+𝑖)′+1−𝑢𝑖 ∙ �1 − 𝑝(𝑎3+𝑖)′�𝑢𝑖−1�𝑎4𝑖=12𝑢1=1
2
𝑢𝑎4=1
 
∙ � … � ���2 �2(𝑛∙𝑑′ − 1)
𝑣𝑑 − 2 � 𝑝𝑑′𝑣𝑑−1(1 − 𝑝𝑑′)2𝑛∙𝑑′+1−𝑣𝑑𝑎3
𝑑=2
𝑛2
𝑣2=2
𝑛𝑎3
𝑣𝑎3=2 + 2 �2(𝑛∙𝑑′ − 1)2𝑛∙𝑑′ − 𝑣𝑑 �𝑝𝑑′2𝑛∙𝑑′+1−𝑣𝑑(1 − 𝑝𝑑′)𝑣𝑑−1� 
∙ �2 ∙ � 2(𝑛∙1′ − 1)
�1 −�1 − 4 (𝑛∙1′(𝑑𝑖𝑓𝑓10)2)⁄ � (𝑛∙1′ + 1) − 2� ∙ 𝑝1′�1−�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓10)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1−�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓10)2�⁄ ��𝑛∙1′+1� 
+� 2(𝑛∙1′ − 1)
�1 + �1 − 4 (𝑛∙1′(𝑑𝑖𝑓𝑓10)2)⁄ � (𝑛∙1′ + 1) − 2� ∙ 𝑝1′�1+�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓10)2�⁄ ��𝑛∙1′+1�−1
∙ (1 − 𝑝1′)2𝑛∙1′+1−�1+�1−4 �𝑛∙1′(𝑑𝑖𝑓𝑓10)2�⁄ ��𝑛∙1′+1���� 
where 𝑑𝑖𝑓𝑓10 ∈ �1 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� , … , 1 �𝑛∙1′ � 𝑛∙1′2𝑛∙1′+2� �1 − 𝑛∙1′2𝑛∙1′+2�� �. 
43 
 
 Next consider case 4 where 𝑎1 = 𝑎2 = 𝑎3 = 0 and 𝑎4 > 0.  Then the joint distribution of 
𝑔1,𝑔2, … ,𝑔𝐽 is  
𝑓�𝑔1,𝑔2, … ,𝑔𝐽�
= �𝑓2�𝑟𝑗′1 = 𝑔𝑗′�𝑎4
𝑗′=2
∙ � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎4+1
∙
⎝
⎜
⎛
2(𝑛∙1′ − 1)(𝑛∙1′ + 1)�1 + �1 − 16 �𝑛∙1′ �𝑔1 −� 𝑔𝑗′𝐽
𝑗′=2
�
2
�� � − 3
⎠
⎟
⎞
∙ 𝑝
1′
�𝑛∙1′+1��1+�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′
𝐽
𝑗′=2
�
2
�� �−1 
∙ (1 − 𝑝1′)2𝑛∙1′+1−�𝑛∙1′+1��1+�1−16 �𝑛∙1′�𝑔1−∑ 𝑔𝑗′𝐽𝑗′=2 �2�� � 
where 𝑔1 − ∑ 𝑔𝑗′
𝐽
𝑗′=2 ∈ �2 �𝑛∙1′ � 12𝑛∙1′+2� �1 − 12𝑛∙1′+2�� , 2 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� �.  
Now sum out 𝑔2, … ,𝑔𝑎4.  Let 𝑑𝑖𝑓𝑓11 = 𝑔1 − ∑ 𝑔𝑗′𝐽𝑗′=𝑎4+1 − ∑ 2
�𝑛∙𝑖′�
𝑢𝑖
2𝑛∙𝑖′+2
��1−
𝑢𝑖
2𝑛∙𝑖′+2
�
𝑎4
𝑖=2  where 
𝑢𝑖 ∈ {1, 2}.  Then the joint distribution of 𝑔1,𝑔𝑎4+1, … ,𝑔𝐽 is 
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𝑓�𝑔1,𝑔𝑎4+1, … ,𝑔𝐽�
= � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎4+1
∙ � � … � ���� 2(𝑛∙𝑖′ − 1)2𝑛∙𝑖′ − 𝑢𝑖 − 1� 𝑝𝑖′2𝑛∙𝑖′+1−𝑢𝑖(1 − 𝑝𝑖′)𝑢𝑖−1�𝑎4
𝑖=2
2
𝑢2=1
2
𝑢𝑎4=1
∙ �
2(𝑛∙1′ − 1)(𝑛∙1′ + 1) �1 + �1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓11)2)⁄ � − 3�
∙ 𝑝
1′
�𝑛∙1′+1��1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓11)2�⁄ �−1 
∙ (1 − 𝑝1′)2𝑛∙1′+1−�𝑛∙1′+1��1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓11)2�⁄ ��� 
where 𝑑𝑖𝑓𝑓11 ∈ �2 �𝑛∙1′ � 12𝑛∙1′+2� �1 − 12𝑛∙1′+2�� , 2 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� �.  Now sum 
over 𝑔𝑎4+1, … ,𝑔𝐽.  Let 𝑑𝑖𝑓𝑓12 = 𝑔1 − ∑ 2
�𝑛∙𝑖′�
𝑢𝑖
2𝑛∙𝑖′+2
��1−
𝑢𝑖
2𝑛∙𝑖′+2
�
𝑎4
𝑖=2  where 𝑢𝑖 ∈ {1, 2}.  Then the 
distribution of the genetic score, 𝑔1, for this case is 
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𝑓(𝑔1) = � 𝑓1�𝑟𝑗′1 = 𝑔𝑗′�𝐽
𝑗′=𝑎4+1
∙ � � … � ���� 2(𝑛∙𝑖′ − 1)2𝑛∙𝑖′ − 𝑢𝑖 − 1� 𝑝𝑖′2𝑛∙𝑖′+1−𝑢𝑖(1 − 𝑝𝑖′)𝑢𝑖−1�𝑎4
𝑖=2
2
𝑢2=1
2
𝑢𝑎4=1
∙ �
2(𝑛∙1′ − 1)(𝑛∙1′ + 1) �1 + �1 − 16 (𝑛∙1′(𝑑𝑖𝑓𝑓12)2)⁄ � − 3�
∙ 𝑝
1′
�𝑛∙1′+1��1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓12)2�⁄ �−1 
∙ (1 − 𝑝1′)2𝑛∙1′+1−�𝑛∙1′+1��1+�1−16 �𝑛∙1′(𝑑𝑖𝑓𝑓12)2�⁄ ��� 
Where 𝑑𝑖𝑓𝑓12 ∈ �2 �𝑛∙1′ � 12𝑛∙1′+2� �1 − 12𝑛∙1′+2�� , 2 �𝑛∙1′ � 22𝑛∙1′+2� �1 − 22𝑛∙1′+2�� �. 
Now consider case 5 where 𝑟11 = ⋯ = 𝑟𝐽1 = 0, then 𝑔1 = 0 and the joint distribution of 
𝑔1,𝑔2, … ,𝑔𝐽 is 
𝑓�𝑔1,𝑔2, … ,𝑔𝐽�
= �����2�𝑛∙𝑗′ − 1�
𝑡 − 1 � ∙ 𝑝𝑗′𝑡−1 ∙ �1 − 𝑝𝑗′�2𝑛∙𝑗′+1−𝑡 + � 2�𝑛∙𝑗′ − 1�2𝑛∙𝑗′ + 1 − 𝑡�
𝑛∙𝑗′
𝑡=3
𝐽
𝑗′=1
∙ 𝑝
𝑗′
2𝑛∙𝑗′+1−𝑡 ∙ �1 − 𝑝𝑗′�𝑡−1� + ���2�𝑛∙𝑗′ − 1�
𝑡 − 1 � ∙ 𝑝𝑗′𝑡−1 ∙ �1 − 𝑝𝑗′�2𝑛∙𝑗′+1−𝑡�2
𝑡=1
+ �2�𝑛∙𝑗′ − 1�𝑛∙𝑗′ � ∙ 𝑝𝑗′𝑛∙𝑗′ ∙ �1 − 𝑝𝑗′�𝑛∙𝑗′�. 
Notice that the above distribution does not depend on the individual 𝑔𝑗′’s and for each 𝑔𝑗′  there 
is only one possible value of zero.  Hence when the ancillary variables are summed out the 
marginal distribution of the genetic score when 𝑔1 = 0 is 
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𝑓(𝑔1) = �����2�𝑛∙𝑗′ − 1�
𝑡 − 1 � ∙ 𝑝𝑗′𝑡−1 ∙ �1 − 𝑝𝑗′�2𝑛∙𝑗′+1−𝑡 + � 2�𝑛∙𝑗′ − 1�2𝑛∙𝑗′ + 1 − 𝑡� ∙ 𝑝𝑗′2𝑛∙𝑗′+1−𝑡
𝑛∙𝑗′
𝑡=3
𝐽
𝑗′=1
∙ �1 − 𝑝𝑗′�𝑡−1� + ���2�𝑛∙𝑗′ − 1�
𝑡 − 1 � ∙ 𝑝𝑗′𝑡−1 ∙ �1 − 𝑝𝑗′�2𝑛∙𝑗′+1−𝑡�2
𝑡=1
+ �2�𝑛∙𝑗′ − 1�𝑛∙𝑗′ � ∙ 𝑝𝑗′𝑛∙𝑗′ ∙ �1 − 𝑝𝑗′�𝑛∙𝑗′�. 
As demonstrated in the previous derivations the distribution of the genetic score can be 
tedious to calculate.  It requires the values of 𝑟11, 𝑟21, … , 𝑟𝐽1 in order to know which case the 
resulting distribution the function lies in.  Additionally there exist nuisance parameters, 𝑝𝑗′  , 
𝑗′ = 1, . . , 𝐽.  Since these are unknown the exact probabilities in the distribution cannot be 
calculated.  Additionally the functions are sensitive to the 𝑝𝑗′’s.  For example if a 𝑝𝑗′  is increased 
then the probability the genetic score equals zero is decreased.  For these reasons the distribution 
of the genetic scores is not used to calculate a test statistic rather a Krusal-Wallis test is used since 
the distribution of the genetic scores is skewed and possibly contains outliers. 
The multinomial weighted sum statistic has the advantage that it simultaneously 
considers all variants at a locus.  This is not the only approach to take.  A marker by marker 
approach such as the one detailed in the next section can pinpoint associations at variants. 
2.2 Single Marker Analysis for Multinomial Data 
 A Single Marker Analysis (SMA) is also proposed to perform association analysis.  The 
hypotheses tested are: 
 H0: The phenotype and marker are statistically independent. 
 Ha: There is an association between the phenotype and marker. 
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In this method each marker is tested individually then a multiple testing correction is used to 
determine if the result is significant enough to warrant rejecting the null hypothesis.   
 First a phenotype by genotype contingency table is constructed.  Observations missing 
the phenotype or genotype are excluded from the test.  As in the typical contingency analysis, for 
each cell in the table the estimated expected cell count is calculated as the row total times the 
column total divided by the number of observations in the table.  If the expected cell count for 
any cell in the table is less than five then an exact test is used.  This routine returns the exact p-
value for an observed contingency table using the hypergeometric distribution with fixed row and 
column totals.  If all of the cell counts were five or greater then a Chi-square test of independence 
is run using Pearson’s statistic. 
2.2.1 Multiple Testing Correction 
The above described SMA only provides results for a single test at a single marker.  In 
practice these tests are used multiple times at different markers to search for an association across 
the locus.  Therefore it is important to use a multiple testing correction when making conclusions.  
The False Discovery Rate (FDR) controlling procedure proposed by Benjamini and Hochberg 
(1995) is used to adjust for the large number of tests being simultaneously run.  This method 
differs from a Family-Wise Error Rate (FWER) control in that it controls the number of false 
positives rather than the probability of making a single Type I error.  This method has been 
shown to have higher power than a traditional FWER control (Benjamini & Hochberg, 1995).  In 
general this method assumes the test statistics are independent.  There are special cases of 
dependency of the test statistics where the results still hold (Benjamini & Yekutieli, 2001).  One 
of these cases is for positively correlated tests.  When linkage disequilibrium exists the tests are 
positively correlated (Verhoeven, Simonsen, & McIntyre, 2005).  An adjustment can be made to 
the procedure if dependency outside of the special cases exists (Benjamini & Yekutieli, 2001).   
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Define Q as the proportion of false rejections among all rejections, then the Benjamini 
and Hochberg FDR is the 𝐸(𝑄).  The Benjamini and Hochberg procedure considers testing D null 
hypotheses, 𝐻01, … ,𝐻0𝐷, using observed significance levels, 𝑃1, … ,𝑃𝐷.  The first step in the 
procedure is to order the observed significance levels so that 𝑃(1) ≤ ⋯ ≤ 𝑃(𝐷).  Denote the null 
hypothesis corresponding to the ordered observed significance level 𝑃(𝑙) as 𝐻0(𝑙).  Find 
𝑑 = 𝑚𝑎𝑥 �𝑙:𝑃(𝑙) ≤ 𝑙𝐷 𝛼� 
and reject 𝐻0(1), … ,𝐻0(𝑑).  If the above d does not exist then none of the null hypotheses are 
rejected.  Let 𝐷0 be the number of true null hypotheses.  For this procedure it is the case that 
(Benjamini & Hochberg, 1995) 
𝐸(𝑄) ≤ 𝐷0
𝐷
𝛼 ≤ 𝛼. 
Hence the procedure controls the FDR at the 𝛼 ∙ 𝐷0 𝐷⁄  level. 
2.3. Multinomial Logistic Regression 
 Multinomial logistic regression is also proposed to test for an association between a 
nominal phenotype with more than two categories and rare variants.  This method is the 
multivariate generalized linear model approach.  Multinomial logistic regression is called many 
different names.  It can also be called polychotomous, polytomous, or baseline-category logistic 
regression.   The model begins by choosing a baseline category.  Continuing the notation above 
let the categories in the phenotype be indexed with k = 1, …, K.  Any category can be chosen as 
the baseline.  For clarity let the baseline category by the Kth category.  The multinomial logistic 
model simultaneously compares category K with the other K – 1 categories.  Let Y be the 
phenotype.  Dummy variables were created for the genotypes at the variants.  Normally two 
dummy variables would be needed for each marker since there are three genotypic categories.  
49 
 
However since these markers are rare variants it is possible only one dummy variable is necessary 
for a given marker.  Let 𝑗∗ = 1, … , 𝐽∗ index the dummy variables of genotypes.  Let 𝑋𝑖𝐽∗  be the 
𝑗∗th dummy variable for the ith individual.  Let 𝑿𝑖 = �𝑋𝑖1, … ,𝑋𝑖𝐽∗�′ be the column vector for the 
ith individual.    Extending the notation from a logistic model, let for category k 
𝜋𝑘(𝑿𝑖) = 𝑃(𝑌 = 𝑘|𝑿𝑖) 
with ∑ 𝜋𝑘(𝑿𝑖)𝑘 = 1.  Under this set up for an arbitrary 𝑿, the counts in the K categories have a 
multinomial distribution with probabilities 𝜋1(𝑿), . . . ,𝜋𝐾−1(𝑿) such that 𝜋𝐾(𝑿) = 1 −
∑ 𝜋𝑘(𝑿)𝑘 .  The baseline category is paired with each other category in a logit model.  The model 
is then K– 1 simultaneous models 
𝑙𝑛
𝜋𝑘(𝑿)
𝜋𝐾(𝑿) = 𝑎𝑘 + 𝜷𝑘′ 𝑿 
for k = 1, …, K – 1 with 𝑎𝑘 an intercept term and 𝜷𝑘 a column vector of coefficients for the kth 
model (Agresti, 2002).  Rewriting the above equations, the probability of category k is 
𝜋𝑘(𝑿) = 𝑒𝑥𝑝(𝑎𝑘 + 𝜷𝑘′ 𝑿)1 + ∑ 𝑒𝑥𝑝(𝑎ℎ + 𝜷ℎ′ 𝑿)𝐾−1ℎ=1  
where 𝛼𝐾 = 0 and 𝜷𝐾 = 0.  For the phenotype of the ith individual let 𝒚𝑖 = (𝑦𝑖1, … ,𝑦𝑖𝐾) where 
𝑦𝑖𝑘 is one if the phenotype is in category k and zero otherwise.  Notice for each individual 
∑ 𝑦𝑖𝑘𝑘 = 1.  Formally define the parameters for the kth logit as 𝜷𝑘 = �𝛽𝑘1, … ,𝛽𝑘𝐽∗�′.  Also note 
that 𝜋𝐾(𝑿𝑖) = 1 − ∑ 𝜋𝑘(𝑿𝑖)𝐾−1𝑘=1 , 𝜋𝐾(𝑿𝑖) = 1 �1 + ∑ 𝑒𝑥𝑝(𝑎𝑘 + 𝜷𝑘′ 𝑿)𝐾−1𝑘=1 �⁄  and 𝑦𝑖𝐾 = 1 −
∑ 𝑦𝑖𝑘
𝐾−1
𝑘=1 .  To find the log likelihood first consider the contribution of individual i 
ln � 𝜋𝑘(𝑿𝑖)𝑦𝑖𝑘𝐾
𝑘=1
� = �𝑦𝑖𝑘 ln𝜋𝑘(𝑿𝑖)𝐾−1
𝑘=1
+ �1 −� 𝑦𝑖𝑘𝐾−1
𝑘=1
� ln𝜋𝐾(𝑿𝑖) 
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= �𝑦𝑖𝑘 ln𝜋𝑘(𝑿𝑖)𝐾−1
𝑘=1
− � 𝑦𝑖𝑘
𝐾−1
𝑘=1
 ln𝜋𝐾(𝑿𝑖) + ln𝜋𝐾(𝑿𝑖) 
= �𝑦𝑖𝑘[ln𝜋𝑘(𝑿𝑖) − ln𝜋𝐾(𝑿𝑖)]𝐾−1
𝑘=1
+ ln 11 + ∑ exp(𝑎𝑘 + 𝜷𝑘′ 𝑿)𝐾−1𝑘=1  
= �𝑦𝑖𝑘 ln 𝜋𝑘(𝑿𝑖)𝜋𝐾(𝑿𝑖)𝐾−1𝑘=1 − ln �1 + � exp(𝑎𝑘 + 𝜷𝑘′ 𝑿)𝐾−1𝑘=1 � 
= �𝑦𝑖𝑘 exp(𝑎𝑘 + 𝜷𝑘′ 𝑿)𝐾−1
𝑘=1
− ln �1 + � exp(𝑎𝑘 + 𝜷𝑘′ 𝑿)𝐾−1
𝑘=1
� 
Note that the constant term 𝑛! [𝑦𝑖1! … 𝑦𝑖𝐾!]⁄  in the multinomial distribution was excluded above 
since it does not contribute to the information about the parameters.  Now consider the full log 
likelihood based on n independent observations.   
ln�� 𝜋𝑘(𝑿𝑖)𝑦𝑖𝑘𝐾
𝑘=1
�
𝑛
𝑖=1
= � ln � 𝜋𝑘(𝑿𝑖)𝑦𝑖𝑘𝐾
𝑘=1
�
𝑛
𝑖=1
 
= ��� 𝑦𝑖𝑘 exp(𝑎𝑘 + 𝜷𝑘′ 𝑿)𝐾−1
𝑘=1
− ln �1 + � exp(𝑎𝑘 + 𝜷𝑘′ 𝑿)𝐾−1
𝑘=1
��
𝑛
𝑖=1
 
The model is fit and maximum likelihood estimates are found by maximizing the log likelihood 
function using the Newton-Raphson or similar algorithm (Croissant).  The null hypothesis of no 
association is 𝐻𝑜:𝜷1 = ⋯ = 𝜷𝐾 = 0.  A likelihood ratio test is used to test this hypothesis.  The 
log likelihood of the full model, ln𝐿, is compared to the log likelihood under the null hypothesis, ln𝐿0.  The test statistic is (Hosmer & Lemeshow, 2000, p. 270) 
−2(ln𝐿0 − ln 𝐿) ∼̇ 𝜒𝐽∗(𝐾−1)2  
and 𝐻0is rejected for large values of the test statistic. 
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2.4 Multinomial Logistic Regression with Collapsing 
The genotypes of the rare variants are converted to dummy variables for use in the 
multinomial logistic regression.  Since the rare allele made some genotypes occur only a few 
times in the data set it is possible that all individuals in a phenotypic category had the same value 
of the dummy variable.  This phenomenon is called quasi-complete separation.  Due to the nature 
of the data, quasi-complete separation occurs frequently.  Quasi-complete separation is 
unavoidable in the data sets since dummy variables for the rare variants are necessary.  When 
quasi-complete separation occurs between an independent variable and the dependent variable in 
multinomial logistic regression, the maximum likelihood estimate for the coefficient to the 
independent variable does not exist (Albert & Anderson, 1984).  Since the MLE does not exist a 
maximum point of the log likelihood function does not exist.  Rather the log likelihood is 
maximized in the limit.  This leads to problems when the maximization routine tries to find a 
maximum that does not exist.  Combining variables together is recommended by Allison (2008) 
as a possible way to allow the routine to find a solution.  Using this suggestion any dummy 
variables with quasi-complete separation are collapsed together to form one dummy variable.  
This dummy variable takes the value of one if at least one variant from the collapsing group 
contains the rare allele and is zero otherwise.  Multinomial logistic regression is then used to test 
for an association as described in the previous section.
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CHAPTER III 
 
 
SIMULATIONS 
 
 To assess the performance of the previously proposed tests, simulations were run under 
different scenarios that might affect the type I error and power.  Section 3.1 gives the factors 
considered.  Section 3.2 details the steps in the simulation process.       
3.1 Scenarios Considered 
 The factors considered in the simulations were sample size, number of phenotypic 
categories, and heritability under the alternative hypothesis.  Initially sample sizes of 500, 1000, 
and 2000 were utilized in the simulations.  Three, five, and seven phenotypic categories were 
considered.  For simulations under the alternative hypothesis the heritability in the broad sense 
was varied with lambda set as 0.01, 0.05, 0.1, 0.2, 0.3, 0.5, or 0.8.   
In order to make recommendations on sample sizes additional simulations were run for 
the heritability in the broad sense of 5%, 10% and 20%.  These heritability levels were chosen 
based on the fact that most genome wide association studies using common variants can account 
for 5% to 10% of the heritability (Asimit & Zeggini, 2010).  Sample sizes were chosen so that the 
proposed weighted sum test and SMA could achieve at least 80% power with three, five, and 
seven phenotypic categories.
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3.2 Steps in the Simulations 
Generation of genetic markers and phenotypes was accomplished by modifying a 
procedure described by Morris and Zeggini (2010).  The goal in generating the data was to 
simulate sampling diploid individuals with rare variants and a multinomial phenotype from a 
population of 20,000.  One thousand iterations were run for each combination of the parameters 
given in the previous section.  The following steps describe how a single iteration of the 
algorithm was run.  The steps include the details used for simulating under the null or alternative 
hypothesis. 
1. A population of 40,000 haplotypes in a 50,000 base pair region is created using the ms 
program (UNIX platform) by Hudson (2002).  Recombination is assumed and a crossover 
rate of 1 cM per million base pairs is used as in Morris and Zeggini.  Additionally a per 
base mutation rate of 10-8 and an effective population size of 10,000 is also taken from 
Morris and Zeggini.  Justification for these choices of parameters is not provided by 
Morris and Zeggini.  It is assumed these parameters are reasonable for simulating a 
population of haplotypes.  Two parameters, θ and ρ, are required in the call to the ms 
program.  The first is calculated as 𝜃 = 4𝑁0𝜇 where 𝑁0is the diploid effective population 
size and 𝜇 is the locus neutral mutation rate.  The second parameter is the cross over rate 
parameter, ρ.  It is calculated as 𝜌 = 4𝑁0𝑟 where r is the probability of crossover 
between ends of the locus.  The correctly scaled parameters as used by Morris and 
Zeggini aee calculated as: 
𝜃 = 4(10,000)(50,000)(10−8) = 20 
𝜌 = 4(10,000)(50,000 − 1)� 1 100⁄1,000,000� = 19.9996 ≈ 20 
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The call to the ms program is “./ms nsam nrep –t 𝜃 –r 𝜌 nsites > output/temp1” where 
nsam = 40000, nrep = 1, 𝜃 = 20, 𝜌 = 20, and nsites = 50000.  The “> ouput/temp1” 
section of the call saves the ms data to an external file for later.  
2. The data set produced by ms is read into R (R Development Core Team, 2011).  The 
minor allele frequency (MAF) is calculated for each marker.  Only rare variants, markers 
with a MAF of 5% or less, are kept for analysis.  It is important to note that Morris and 
Zeggini (2010) as well as Li and Leal (2008) define a rare variant as a marker with a 
MAF of 1% or less.  For simulations under the alternative hypothesis of association, 
markers are randomly selected to be causal so that the total MAF of the markers is 
approximately 10%.   
3. At this point it is necessary to capture a population parameter for simulations under the 
alternative before the sample is collected.  The use of this parameter is explained in a 
later step.  It is desired to calculate the probability that all causal alleles are the wild type 
in the individual.  Let 𝑏𝑖 be the number of rare causal alleles across the whole locus for 
diploid individual i.  Hence it is desired to calculate 𝑃(𝑏𝑖 = 0) in the population.  Since 
the data set contains haplotypes not individuals the probability can not be directly 
calculated.  Originally, pairing of all 40,000 haplotypes was considered to create 
individuals so this quantity could be calculated.  However the procedure proved to be too 
computationally intensive to run in a reasonable amount of time.  A theoretical equivalent 
is produced using the haplotypes.  Let 𝐵1𝑖 be the number of causal rare alleles in 
haplotype 1 and 𝐵2𝑖 be the number of causal rare alleles for haplotype 2 paired with 
haplotype 1.  Then 𝑏𝑖 = 𝐵1𝑖 + 𝐵2𝑖 since the sum in the individual can be broken into the 
haplotypes.  Due to the fact that haplotypes are randomly paired and assumed 
independent it can be shown: 
𝑃(𝑏𝑖 = 0) = 𝑃(𝐵1𝑖 = 0 ∩ 𝐵2𝑖 = 0) 
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= 𝑃(𝐵1𝑖 = 0) ∙ 𝑃(𝐵2𝑖 = 0) = [𝑃(𝐵1𝑖 = 0)]2 
Hence the only differences between 𝑃(𝑏𝑖 = 0) and [𝑃(𝐵1𝑖 = 0)]2 are due to the exact 
random pairing performed.  The final equation is simply the square of the probability that 
all causal alleles are wild type on one haplotype.  The quantity [𝑃(𝐵1𝑖 = 0)]2 is 
calculated from the generated population and saved for later in the simulation process 
when the parameter 𝑃(𝑏𝑖 = 0) is needed.  Under the null hypothesis this quantity is not 
calculated since there are no causal alleles. 
4. A sample of 2N haplotypes is randomly selected.  These haplotypes are randomly paired 
together to create diploid organisms.  Since a sample is taken from the population it is 
possible that a rare variant had a MAF of greater than 5%.  It is also possible that for 
some markers no rare alleles made it into the sample. 
5. For generating phenotypic data under the alternative hypothesis of association, 𝑏𝑖, the 
number of rare causal alleles across the whole locus for each individual is calculated.  
The quantity λ is defined as the heritability in the broad sense.  Morris and Zeggini 
(2010) simulate the phenotype from a 𝑁(𝐼(𝑏𝑖 > 0),𝜎2) but do not give a formula for the 
variance or standard deviation.  They simply state that “the standard deviation, σ, is 
determined by the spectrum of causal variants and their joint contribution, λ, to the 
phenotypic variance” (Morris & Zeggini, 2010).  To derive the formula for the variance it 
may be helpful to recall from Bain and Englehardt (Introduction to Probability and 
Mathematical Statistics, 1992) Theorem 5.4.3: 
𝑉𝑎𝑟(𝑌) = 𝐸𝑋[𝑉𝑎𝑟(𝑌|𝑋)] + 𝑉𝑎𝑟𝑋[𝐸(𝑌|𝑋)]. 
The conditional distribution 𝑦𝑖|𝑏𝑖~𝑁(𝐼(𝑏𝑖 > 0),𝜎2) is the normal variable that Morris 
and Zeggini generated in their simulations.  Note that for the mean in the normal variable 
it is the case that 𝐼(𝑏𝑖 > 0)~𝐵𝑒𝑟𝑛𝑜𝑢𝑙𝑙𝑖�𝑃(𝑏𝑖 > 0)�.  It is desired to avoid making any 
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assumptions about the individual markers.  Linkage disequilibrium is possible under the 
following results.  Given the above conditional distribution it is necessary to know the 
variance of the resulting, 𝑦𝑖’s.  The variance is: 
𝑉𝑎𝑟(𝑦𝑖) = 𝐸𝑏𝑖[𝑉𝑎𝑟(𝑦𝑖|𝑏𝑖)] + 𝑉𝑎𝑟𝑏𝑖[𝐸(𝑦𝑖|𝑏𝑖)] = 𝐸𝑏𝑖[𝜎2] + 𝑉𝑎𝑟𝑏𝑖[𝐼(𝑏𝑖 > 0)] = 𝜎2 + 𝑃(𝑏𝑖 > 0)�1 − 𝑃(𝑏𝑖 > 0)� = 𝜎2 + [1 − 𝑃(𝑏𝑖 = 0)][𝑃(𝑏𝑖 = 0)] 
The first term in the last equality is the variance of the environmental effects, 𝑉𝑎𝑟(𝐸), in 
the usual equation 𝑉𝑎𝑟(𝑃) = 𝑉𝑎𝑟(𝐺) + 𝑉𝑎𝑟(𝐸).  The second term is the variance of the 
genetic effects.  The heritability in the broad sense is written as: 
𝜆 = 𝑉𝑎𝑟(𝐺)
𝑉𝑎𝑟(𝐺) + 𝑉𝑎𝑟(𝐸). 
Solving for the 𝑉𝑎𝑟(𝐸) obtains 
𝑉𝑎𝑟(𝐸) = 1 − 𝜆
𝜆
𝑉𝑎𝑟(𝐺). 
Thus the variance in the conditional distribution needed to be  
𝜎2 = 1 − 𝜆
𝜆
[1 − 𝑃(𝑏𝑖 = 0)][𝑃(𝑏𝑖 = 0)] 
in order to have the correct heritability in 𝑦𝑖.  Recall it was not computationally efficient 
to calculate 𝑃(𝑏𝑖 = 0) in the population.  Thus the theoretical equivalent [𝑃(𝐵1𝑖 = 0)]2 
saved in step 3 is used in its place.  Under the null hypothesis of no association a random 
variable from a standard normal distribution is generated in place of 𝑦𝑖.  To obtain the 
categorical phenotypes, the empirical percentiles of the 𝑦𝑖’s are used to divide the data 
into the desired number of categories.  For example when five categories are needed the 
quintiles are used to divide the 𝑦𝑖’s into five categories.  The generated data set thus 
consists of a categorical phenotype and all rare variants.  For simulations under the null 
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hypothesis these rare variants are all non-causal.  For simulations under the alternative 
hypothesis these rare variants are a mixture causal and non-causal variants.   
6. The proposed methods from Chapter 2 are applied to the generated data set.   
a. The proposed weighted sum statistic test deriving a p-value from the appropriate 
chi-square distribution is the test of interest.  The p-value is compared to a 0.05 
level to determine a decision.  In addition to this version of the test, a 
permutation test is run to find an empirical p-value for the weighted sum test 
statistic.  This is done to show that the permutation test is not necessary when the 
observations are independent.     
b. The previously described single marker analysis (SMA) is also performed.  If the 
expected cell count for any cell in the contingency table is less than five then an 
exact test through the fisher.test() function in R was used.  This function uses the 
FEXACT routine created by Mehta and Patel (1986) and modified by Clarkson, 
Fan, and Joe (1993) to run the Fisher’s exact test when the table is larger than 2 × 2.  If all of the expected cell counts are greater than five then the usual Chi-
square test is run in R.  A false discovery rate (FDR) of α = 0.05 is used in the 
algorithm.  The procedure results in a decision for each test.  If any decision is to 
reject then the whole SMA is counted as significant.  Thus a significant result 
does not mean that all variants were rejected.  Rather it means that at least one 
test on the locus produced a decision to reject.   
c. Two versions of multinomial logistic regression (with and without collapsing) are 
also considered to test for association as described in Chapter 2.  Linear 
dependencies and dummy variables with only one value are eliminated by using a 
Gaussian elimination function provided by John Fox (2007) on the R help forum.  
This is necessary because the multinomial logistic regression function in R does 
not tolerate linear dependencies or redundant variables.  To run the multinomial 
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logistic regression the R package mlogit (Croissant) is utilized.  The package can 
only handle eighty-five variables at a time so if necessary the independent 
variables are split into two groups and two models are run.  In this case eighty-
five variables are included in the first model and the remaining in the second 
model.  If splitting the variables is necessary then a Bonferonni correction to a 
0.05 level is used to adjust the type I error for the two tests.  In the case of two 
models if either of the decisions are to reject then the result is counted as 
significant.  If only one test is needed then a 0.05 level is used for making a 
decision. 
7. A tally of the number of significant tests is kept.  If a test is significant then one is added 
to the counting variable for that test.  During initial testing it became clear that there is a 
huge problem with using the mlogit package for the multinomial logistic regression.  The 
model fitting failed numerous times when the hessian became computationally singular.  
For both versions of the multinomial logistic regression routines the number of times the 
routine succeeded are counted.   
As noted above these steps were run 1000 times for each combination of the parameters.  
The proportion of significant tests was used to estimate the type I error under the null hypothesis 
and power under the alternative.  Estimates for the multinomial logistic regression methods used 
the number of times the routines succeeded not the number of tests attempted to calculate these 
proportions.  The results of the simulations are presented in the following chapter.
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CHAPTER IV 
 
 
RESULTS 
 
 The results of the simulations described in chapter III are detailed here.  Section 4.1 
discusses of the number of rare variants generated in the simulations as well as the number of 
causal variants simulated.  Section 4.2 presents the Type I error estimates of the methods 
considered.  Power estimates are provided and discussed for the viable methods in section 4.3.  
Section 4.4 gives sample size recommendations for the recommended methods. 
4.1 Number of Markers and Causal Markers 
 In order for this work to be comparable to future work, the number of variants considered 
in each test is needed.  Many previous researchers fixed the number of variants generated in each 
data set and the number of causal variants (Basu & Pan, 2011; Li & Leal, 2008; Madsen & 
Browning, 2009).  The data generation procedure used in these simulations allows the number of 
variants and causal variants to fluctuate.  Table 4.1 provides the five number summaries plus the 
standard deviation of the number of rare variants and causal variants generated in the simulations 
and testing.  The number of rare variants includes 101,900 iterations of the data generation 
procedure (due to a failure in the file system on Pistol Pete at Oklahoma State University 100 
iterations of the data was lost).  The number of rare variants was generated under both the null  
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Number of Rare Variants 
Minimum 
1st 
Quartile Median Mean 
3rd 
Quartile Maximum Standard Deviation 
218 310 328 329.3 348 476 29.1 
       Number of Causal Rare Variants 
Minimum 
1st 
Quartile Median Mean 
3rd 
Quartile Maximum Standard Deviation 
3 13 17 18.4 23 69 7.7 
Table 4.1: Statistics for the Number of Rare Variants and Causal Variants 
 
Figure 4.1: Histogram of the Number of Rare Variants 
and alternative hypothesis.  The number of causal variants came exclusively from simulations 
under the alternative hypothesis.  The histogram of the number of rare variants generated in each 
simulation is provided in Figure 4.1.  Both Table 4.1 and Figure 4.1 show the empirical 
distribution is bell shaped.  The mean is approximately 329.3 rare variants generated.  This is 
many more than the 100 variants that Madsen and Browning used in their simulations (2009).  It 
is also many more than the 5 to 20 variants Li and Leal (2008) simulated and the 8 to 72 variants 
Basu and Pan (2011) used.  Figure 4.2 gives the histogram of the number of causal variants 
generated under the alternative hypothesis.  The number of causal rare variants is slightly right 
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skewed.  Recall from the description of the data generation process that the total MAF of causal 
variants is set to 10%.  Hence a large number of causal variants means that many of them are 
extremely rare.   
 
Figure 4.2: Histogram of the Number of Causal Variants  
4.2 Comparison of Type I Error 
The Type I error estimates for all of the methods applied to the simulated data are 
presented in Table 4.2.  Each estimate is based on 1000 iterations.  The data for these simulations 
are generated under the null hypothesis of no association.  Table 4.2 gives the proportion of false 
rejections for each method considered for all tests at a 0.05 level.  The multinomial logistic 
regression methods encountered failures in the routine for some iterations.  The symbol † is used 
to mark scenarios where failures occurred.  The estimates given in these cells are based on the 
successful iterations not the number of iterations tried.  Additionally estimates that are 
significantly different from 0.05 at a 0.05 level are marked with the symbol *.  Estimates different 
62 
 
from 0.05 are determined using the appropriate rejection region for a z-test of 𝐻0:𝑝 = 0.05 
versus 𝐻𝑎:𝑝 ≠ 0.05.  
    Number of Phenotypic Categories 
Sample 
Size Method 3 5 7 
500 MNWSS 0.045 0.055 0.040 
 
NMWSSP 0.045 0.058 0.043 
 
SMA 0.01* 0.012* 0.009* 
 
MLOGIT 0.3567†* 0.0951†* 0.0089†* 
  MLOGITC 0.019* 0.019* 0.0130†* 
1000 MNWSS 0.042 0.040 0.055 
 
NMWSSP 0.042 0.042 0.056 
 
SMA 0.013* 0.013* 0.018* 
 
MLOGIT 0.232* 0.0911†* 0.0067†* 
 
MLOGITC 0.018* 0.0285†* 0.0311†* 
2000 MNWSS 0.055 0.050 0.060 
 
NMWSSP 0.053 0.052 0.053 
 
SMA 0.018* 0.013* 0.012* 
 
MLOGIT 0.2142†* 0.0612†* 0.0115†* 
  MLOGITC 0.006* 0.019* 0.0262†* 
†A portion of these tests failed and the results are most likely biased 
*The Type I Error Rate is significantly different from 0.05 at a 0.05 level. 
Estimates based on 1000 iterations. 
Table 4.2: Type I Error Estimates for All Methods at a 0.05 Level 
First note that the multinomial weighted sum statistic (MNWSS) gives a Type I error rate 
at the desired level of 0.05.  Also note that the results are very similar to the results for the 
multinomial weighted sum statistic with a permutation test (MNWSSP).  This shows that there is 
not a bias in using the distribution based test over the permutation test for these sample sizes.  
Since the distribution based test is computationally simpler, it is recommended over the 
permutation test.   Madsen and Browning used a permutation test in their method and did not 
consider using a distributional quantity.  Given the results of this study it may be possible to 
simplify their procedure by using a distribution based test. 
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The single marker analysis (SMA) for a multinomial phenotype is very conservative for 
all sample sizes and number of categories included in the simulation study. This is expected since 
an adjustment was made for multiple tests.  Basu and Pan found that their SMA on case control 
data was conservative (2011).   
The multinomial logistic regression (MLOGIT) had an inflated Type I Error rate when 
the phenotype had three and five categories.  This is consistent with results for logistic regression 
on case control status (Li & Leal, 2008).  For this reason Li and Leal excluded logistic regression 
from power simulations.  Since multinomial logistic regression has an extremely inflated type I 
error rate it is not a viable method for determining an association between genetic markers and a 
multinomial phenotype.  The method appears to be conservative when the phenotype has seven 
categories.  This might be due to the large number of failures in the routine for seven phenotypic 
categories versus three or five phenotypic categories.  For a sample size of 2000 the multinomial 
logistic regression routine failed in 0.1% of the simulations for 3 phenotypic categories, 0.4% for 
five phenotypic categories, and 30.6% for seven phenotypic categories.  Failures in the 
multinomial logistic regression routine also make it unreliable as a method of association.  For 
these reasons multinomial logistic regression is excluded from consideration in the power 
simulations. 
    Number of Phenotypic Categories 
Sample 
Size Method 3 5 7 
500 MLOGIT 0.002 0.001 0.217 
  MLOGITC 0 0 0.001 
1000 MLOGIT 0 0.001 0.258 
  MLOGITC 0 0.002 0.002 
2000 MLOGIT 0.001 0.004 0.306 
 
MLOGITC 0 0 0.007 
Estimates Based on 1000 iterations. 
Table 4.3: Proportion of Failures in the Multinomial Logistic Regression Routine 
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The multinomial logistic regression with collapsing (MLOGITC) was considered as an 
alternative to the multinomial logistic regression.  Recall that variants with quasi-complete 
separation were collapsed together into a single variable in this method.  The Type I Error 
estimates for MLOGITC are conservative instead of inflated as in the multinomial logistic 
regression.  Unfortunately the method still experiences failures in the multinomial logistic 
regression routine.  These failures make the MLOGITC unreliable.  Hence it is not considered in 
the subsequent power simulations. 
4.3 Comparison of Power 
 This section examines the power estimates of the multinomial weighted sum statistic 
(MNWSS), the multinomial weighted sum statistic with a permutation test (MNWSSP), and a 
single marker analysis for multinomial phenotypes (SMA).  The multinomial logistic regression 
methods are excluded for the previously mentioned reasons.  Results will be grouped together by 
sample size since this factor influenced the power the most. 
 Figure 4.3 illustrates the power estimates for a sample size of 500 with three, five, and 
seven phenotypic categories as heritability is increased.  The multinomial weighted sum statistic 
and multinomial weighted sum statistic with a permutation test have very similar results for most 
of the simulations.  Hence the two lines are overlaid in these figures and many subsequent ones.  
This further illustrates the fact that a permutation test is not necessary.  In each of these figures 
the multinomial weighted sum statistic starts out with a higher power than the SMA.  Recall that 
the multinomial weighted sum statistic had the correct Type I Error rate while the SMA was 
conservative.  The single marker analysis overtakes the multinomial weighted sum statistic 
between a heritability of 1% and 10%.  The single marker analysis quickly reaches a power of 1 
while the multinomial weighed sum statistic increases but does not reach a power of 1.  The 
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similarity of these three figures shows that the methods are only slightly influenced by the 
number of phenotypic categories for a sample size of 500.   
 
Figure 4.3: Power Comparison for a Sample Size of 500 with Three, Five, and Seven Phenotypic 
Categories 
 Figure 4.4 gives the power estimates of the methods for a sample size of 1000 with three, 
five, and seven phenotypic categories.  Again the multinomial weighted sum statistic starts out 
with a higher power than the single marker analysis at a heritability of 1%.  Here the SMA 
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overtakes the MNWSS for the heritability between 1% and 5%.  Again the SMA quickly reaches 
a power of 1 while the MNWSS increases but never reaches a power of 1.     
 
Figure 4.4: Power Comparison for a Sample Size of 1000 with Three, Five, and Seven 
Phenotypic Categories 
 Figure 4.5 gives the power comparisons for a sample size of 2000 with three, five, and 
seven phenotypic categories.  Again for a heritability of 1% the MNWSS has higher power than 
the SMA.  The SMA overtakes the WSS for the heritability between 1% and 5%.  The single 
marker analysis reaches a power of 1 quickly while the MNWSS increases but does not reach 1.    
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Figure 4.5: Power Comparison for a Sample Size of 2000 with Three, Five, and Seven 
Phenotypic Categories 
Figure 4.6 gives a side by side comparison of power for all of the sample sizes and 
phenotypic categories.  This figure illustrates that as sample size increases, the power of the 
methods increase and stabilize at or near one faster.  This figure also shows that there are only 
small differences between the plots for the different number of phenotypic categories.  These 
differences were detailed earlier.   
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Figure 4.6: Side by Side Power Comparison for Sample Size and Phenotypic Categories 
 For each scenario considered above the single marker analysis has a lower power than the 
multinomial weighted sum statistic when the heritability is at 1%.  Recall that the multinomial 
weighted sum statistic had the correct type I error rate while the single marker analysis was 
conservative due to the adjustment for multiple tests.  The single marker analysis quickly gains 
power and over takes the multinomial weighted sum statistic as the heritability increases.  The 
single marker analysis reaches and maintains a power of 1 while the multinomial weighted sum 
statistic increases in power more slowly and never reaches one.  These results are very contrary to 
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the findings reported by Madsen and Browning for their study of the dichotomous case (2009).  
Madsen and Browning reported that the power of their weighted sum statistic for case control 
data increased quickly to 1 and remained there as the population attributable risk increased.  They 
also showed that their single marker analysis always had a power less than 20% for any level of 
population attributable risk.  These results may be specific to the way the data was generated.  
Madsen and Browning started with the case control status then generated the genotypes at each 
variant independently.  The data simulation process for this dissertation study generated a 
population of haplotypes using a coalescent process then allowed the alleles to help determine the 
phenotype.  This process should result in a population that is more realistic of the genetic 
structure of a real population.  Madsen and Browning only used a Fisher’s exact test on each 
variant in their single marker analysis.  This dissertation proposes using the chi-square test of 
independence when all cell counts are five or greater and an exact test when a cell count fall 
below this threshold.  Also Madsen and Browning used the Dunn-Sidak correction (Abdi, 2007) 
on the smallest p-value to determine the significance of the single marker analysis results.  This 
work proposes using the False Discovery Rate controlling procedure of Benjamini and Hochberg 
(1995).  The Benjamini and Hochberg procedure has been shown to be more powerful than the 
Bonferonni correction. 
4.4 Sample Size Recommendations 
 It is intended that these methods will be used by future researchers.  Therefore sample 
size recommendations are necessary for each of the methods.  Since the power heavily depends 
on the heritability of the phenotype it is extremely important to have a good estimate of the 
heritability before proceeding.  The heritability of the trait will vary from phenotype to 
phenotype.  Asimit and Zeggini report that current GWAS on common variants can “explain at 
most 5% - 10% of the heritable component of disease” (2010).  In the absence of an estimated 
heritability due to rare variants, heritability levels of 5%, 10%, and 20% will be investigated.  The 
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highest heritability level is added since it is believed that rare variants can collectively contribute 
more than common variants to the variation of the phenotype.  For heritability levels of 30% and 
above a sample size of 500 will be enough to give a power greater than 80% for both the 
multinomial weighted sum statistic and the single marker analysis.  Results will be discussed by 
the heritability of the phenotype below.  For all of the results below a size 0.05 test is considered. 
 Figure 4.7 visualizes the power versus sample size for a heritability level of 5% with 
three, five, and seven phenotypic categories.  It is desired to determine approximately how many 
observations are necessary to achieve 80% power for both the multinomial weighted sum statistic 
method and the single marker analysis.  The horizontal dashed gray line marks 80% power.   
 First consider three phenotypic categories.  For the multinomial weighted sum statistic 
just a little over 2500 observations are needed to reach 80% power.  The single marker analysis 
needs between 1000 and 1500 observations to reach this power.  Interpolation between these two 
points gives approximately 1294 observations to reach 80% power.  Slightly increasing this 
estimate and the estimates based on interpolation below would be prudent since this is a straight 
line interpolation of a convex line.  Also the points used in the interpolation are estimates of the 
true power.  The large sample sizes required by both methods are mostly due to the low 
heritability of the phenotype.  The large number of non-causal variants in the simulated data 
might also be affecting the power of the multinomial weighted sum statistic. 
Next consider the sample sizes for a heritability of 5% and five phenotypic categories.  
The multinomial weighted sum statistic needs significantly more than 2500 observations to 
achieve an 80% power.  Interpolation between 2500 and 3000 yields a sample size of 
approximately 2654.  Similar to the results for three categories the single marker analysis requires 
between 1000 and 1500 observations to achieve 80% power.  Again using interpolation 
approximately 1393 observations are needed. 
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Figure 4.7: Power versus Sample Size for a Heritability of 5% with Three, Five, and Seven 
Phenotypic Categories 
Finally consider the power curves for a heritability of 5% and seven phenotypic 
categories.  No interpolation is needed for this scenario.  The multinomial weighted sum statistic 
requires approximately 3000 observations to reach a power of 80%.  The single marker analysis 
only needs 1500 observations to reach this power.  Hence the multinomial weighted sum statistic 
requires double the observations needed by the single marker analysis to reach 80% power when 
the heritability is 5% and there are seven categories in the phenotype. 
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Overall for a heritability of 5% as the number of phenotypic categories increased the 
sample size requirement to reach 80% power also increased.  The single marker analysis uses 
either a chi-square test or an exact test at each variant.  These tests are dependent on the number 
of observations in each cell.  Including more phenotypic categories in the test increases the 
number of cells.  Hence the data gets spread over more cells as the phenotypic categories 
increase.  The multinomial weighted sum statistic uses the Kruskal-Wallis test in the procedure.  
Increasing the number of phenotypic categories increases the number of populations the test.  So 
once again the data is spread out as the number of phenotypic categories increases. This spreading 
out of the data could account for the larger sample size requirements in both methods as the 
number of phenotypic categories increases. 
 Next study a heritability level of 10%.  Figure 4.8 gives the power curves for a 
heritability of 10% with three, five, and seven phenotypic categories.  For three phenotypic 
categories the multinomial weighted sum statistic requires between 1000 and 1500 to reach the 
threshold while the single marker analysis needs between 500 and 750 observations.  Again using 
interpolation an approximation can be found for a more exact sample size required.  For the 
multinomial weighted sum statistic approximately 1183 observations are needed.  For the single 
marker analysis approximately 675 observations are needed. 
 Next review the power curves for a heritability of 10% and five phenotypic categories 
displayed in Figure 4.8.  To reach 80% power the multinomial weighted sum statistic needs 
between 1000 and 1500 observations.  Interpolating as before, approximately 1255 individuals 
are needed.  For the single marker analysis between 500 and 750 observations are required to 
reach an 80% power.  Straight line interpolation yields approximately 695 observations. 
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Figure 4.8: Power versus Sample Size for a Heritability of 10% with Three, Five, and Seven 
Phenotypic Categories 
 The final plot in Figure 4.8 maps the power versus sample size for seven phenotypic 
categories when the heritability is 10%.  No interpolation is necessary for this set of parameters.  
The multinomial weighted sum statistic requires approximately 1500 observations to achieve 
80% power.  The single marker analysis only requires 750 observations to achieve this same 
level.  Hence with seven phenotypic categories and a heritability of 10%, the single marker 
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analysis requires only half as many observations to reach 80% power as the multinomial weighted 
sum statistic. 
 Overall the sample size requirements for a heritability of 10% were less than for a 
heritability of 5%.  This is expected since the heritability is a measure of the strength of the 
association between the phenotype and variants.  Similar to the results for the heritability at 5%, 
the sample size requirements increased as the number phenotypic categories increased. 
 Finally examine the power versus sample size for the heritability at 20%.  Figure 4.9 
plots the power curves for three, five, and seven categories in the phenotype.  Once again the gray 
dashed line represents the desired 80% power.  These curves show that both methods reach 80% 
power with smaller sample sizes than considered above.  Also the trend of increasing sample size 
with increasing phenotypic categories continues.   
 Start with the results for three phenotypic categories.  The multinomial weighted sum 
statistic needs between 500 and 750 observations to reach 80% power.  Interpolation gives 
approximately 623 observations.  A sample size of 500 is more than adequate to achieve 80% 
power for the single marker method. 
 The middle plot in Figure 4.9 displays the power versus sample size for a heritability 
level of 20% and five phenotypic categories.  Once again the multinomial weighted sum statistic 
requires between 500 and 750 individuals to achieve 80% power.  Approximating using straight 
line interpolation yields 643 observations.  Similar to before a sample size of 500 is more than 
enough for the single marker analysis to achieve 80% power. 
 The top plot in Figure 4.9 displays the power curves for seven phenotypic categories with 
a heritability level of 20%.  The sample size to reach 80% power for the weighted sum statistic 
lies between 500 and 750 observations.  Interpolating once again finds an approximate sample 
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size of 685.  A sample size of 500 is more than enough to achieve 80% for the single marker 
analysis. 
 
Figure 4.9: Power versus Sample Size for a Heritability of 20% with Three, Five, and Seven 
Phenotypic Categories 
4.5: Summary 
 The multinomial weighted sum statistic and the single marker analysis have a reasonable 
or conservative Type I Error rate.  However the power for these methods is low when the 
heritability is less than 10%.  The results presented here are dependent on the structure of the 
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simulated data.  The large number of non-causal variants in the simulated data may have reduced 
the power for the MNWSS.  It has been demonstrated that pooling methods lose power when a 
large number of non-causal variants are included in the test (Basu & Pan, 2011).  For a 
heritability of 10% to 20% the single marker analysis is recommended even though it is very 
conservative.  For heritability greater than 20% both the multinomial logistic regression and the 
single marker analysis reach reasonably high power.  This does not mean that the multinomial 
weighted sum statistic has a higher power than the single marker analysis for this heritability.  
Rather both have approximately 80% power or greater when the heritability is greater than 20%. 
The multinomial logistic regression is not recommended.  The inflated Type I Error rate 
of the method makes it unsuitable as a method of association.  Additionally the unpredictability of 
the multinomial logistic regression routine makes it unreliable as a method.  Collapsing of 
variants that had quasi-complete separation helped in fixing the inflated Type I Error rate but it 
did not completely resolve the issues with failures in the routine.  For this reason it is also not 
recommended as a method for association.  Further research is needed to devise modifications to 
the multinomial logistic regression methods to make them viable. 
Sample size recommendations were made for heritability levels of 5%, 10%, and 20%.  
Estimates based on straight line interpolation should be slightly increased as noted above.  The 
heritability levels used in the sample size study were arbitrarily chosen.  Other levels may better 
suit the expectations of researchers.  Since the power greatly depends on the heritability, 
additional simulations may be necessary for a given heritability level.  The results of the 
simulation study showed that the proposed single marker analysis required many less 
observations than the multinomial weighted sum statistic to reach 80% power.  The simulation 
study also revealed that as the number of phenotypic categories increases the required sample size 
to reach 80% power increases for both methods.
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CHAPTER V 
 
 
APPLICATION 
 
 In the previous chapter it was shown that the proposed multinomial weighted sum 
statistic (MNWSS) and the single marker analysis (SMA) performed well in simulations for 
reasonable sample sizes.  Ultimately the methods should be applied by analyzing real data.  The 
purpose of this chapter is to show that the methods are viable for analysis on an empirical data 
set.  The data analyzed here is a resequencing study of participants in the Dallas Heart Study at 
the University of Texas Southwestern.  Section 5.1 will begin by describing the data sets 
(including phenotypes in Section 5.1.1 and genotypes in Section 5.1.2) and findings other 
researchers have published on the same data sets.  Section 5.2 will describe the analysis of the 
data using the proposed methods.  Section 5.3 will present the results.  Lastly section 5.4 
compares the results of the proposed methods with other researchers’ findings and provides a 
discussion of the conclusions. 
5.1 Dallas Heart Study Data 
An association between multiple rare variants in the ANGPTL4 gene and plasma 
triglyceride was reported in a resequencing study of Dallas Heart Study participants (Romeo, et 
al., 2007).  Further research using the same cohort found an association between rare variants in 
the ANGPTL3 and ANGPTL5 genes with plasma triglyceride level (Romeo, et al., 2009).  These 
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rare variant associations were further confirmed in an investigation of several case control 
methods (Price, et al., 2010).  In each of these studies the quantitative phenotype, plasma 
triglyceride level, was adjusted for race and gender.  Then a categorical phenotype was created 
using the quartile membership.  Only individuals in the top and bottom quartiles of the adjusted 
plasma triglyceride distribution were included in the tests for association.  This was necessary 
since the tests (see below) could only accommodate two categories.  Excluding the middle fifty 
percent of the distribution decreased the significance of the tests compared to a quantitative test 
on all of the observations (Price, et al., 2010).  The original studies performed at the University of 
Texas Southwestern used a Fisher’s exact test on the number of individuals with nonsynonymous 
variants (nucleotide mutations that change the amino acid sequence) in the categories.  Several 
proposed case control methods were run on the data by Price et al. (2010). 
5.1.1 Phenotype Data Set 
The data consists of two separate data sets.  The first is a set of phenotypic variables and 
several covariates.  The second is a data set of genotypes.  The phenotypic data set contains 3557 
observations, including 1986 females and 1571 males.  For each research participant a subject ID, 
gender, ethnicity, age, body mass index (BMI), statin, and plasma triglyceride were given.  Some 
of the observations included missing values for one or more of the variables.  Treatment of 
missing values is discussed in Section 5.2.  The ethnic groups break down as follows: 603 
Hispanic, 1832 Non-Hispanic Black, 1047 Non-Hispanic White, and 75 other.  The ages of the 
participants ranged from 18 to 65 years old.  Body mass index was also considered as a 
phenotype by the original researchers.  Their studies found no significant associations between 
BMI and any of the genes (Romeo, et al., 2007; Romeo, et al., 2009).  The BMI ranges between 
14.45 and 65.23.  A histogram of the variable of interest, plasma triglyceride level, is presented in 
figure 5.1.  This histogram was generated using the provided data.  The plasma triglyceride level 
ranges from 21 to 1669.   
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Figure 5.1: Histogram of Triglycerides 
5.1.2 Genotype Data Set 
The second data set contains genotypes.  The data set is a list of mutant genotypes.  There 
are 15819 records in the data set.  For each record the gene, subject ID, mutation ID, mutation 
type, and genotype are given.  The genotypes are coded as 1 for heterozygous and 2 for 
homozygous for the mutant allele.  None of the wild type homozygous genotypes are listed in the 
data set.  Rather they are implied by their absence.  There are three separate genes with genotype 
data available.  They are ANGPTL3, ANGPTL4, and ANGPTL5.  The subject ID is not unique in 
this data set since some subjects have multiple mutations.  Subjects with only wild type alleles are 
not listed in the genotype data set.  The mutation ID gives the name of the mutation.  There are 
282 unique mutations in the data set.  They are typed as frame shift, intronic, missense, 
noncoding, nonsense, or synonymous.  The minor allele frequencies of the mutations are 
80 
 
presented in figure 5.2.  There are eleven mutations that are not rare variants.  The remaining 271 
mutations are rare variants.  The inclusion/exclusion of these variants in the analysis is discussed 
in section 5.3. 
 
Figure 5.2: Histogram of Minor Allele Frequencies 
5.2 Analysis Methods 
The phenotype, plasma triglyceride level, was adjusted and categorized by previous 
researchers prior to analysis.  Before adjusting the phenotype individuals taking statins, lipid 
lowering medicines, were excluded from the analysis.  This was also done by the original studies 
(Romeo, et al., 2007; Romeo, et al., 2009).  The original studies also excluded individuals with 
diabetes, men consuming more than 30g of alcohol a day, and women consuming more than 20g 
of alcohol a day.  Since diabetes information and alcohol consumption were not made available it 
is unknown whether these individuals remain in the data set for this analysis.  The adjustment and 
categorization described below was adapted from the procedure used by Price et al. (2010).  First 
eight groups were formed by the combinations of gender and ethnicity.  Within each group the 
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plasma triglyceride was standardized.  This adjusted triglyceride level was then categorized using 
the quartiles.  The first category is the lowest quartile.  The second category is the middle 50% of 
the distribution.  The last category is the upper quartile.  Previous researchers discarded the 
second category (Romeo, et al., 2007; Romeo, et al., 2009; Price, et al., 2010).  For this research 
it is kept and included in the analysis since the methods previously proposed can accommodate 
more than two categories.  Individuals missing plasma triglyceride were given a missing value for 
the phenotype. 
The genotype data was not in a commonly used format and required some restructuring.  
As mentioned before, the genotype data is a list of mutant genotypes and does not include wild 
type genotypes.  An individual will have multiple observations in the genotype file if the 
individual has a mutant genotype at multiple SNPs.  Likewise an individual will have no 
observations in the genotype file if all genotypes are the wild type homozygous.  This 
necessitated some additional processing so that the proposed methods could be applied.  Prior to 
running the analysis a data set containing one observation for each participant and one variable 
for each variant was created from the genotype data file.  For each variant the genotype is coded 
as “0” for the homozygous wild type, “1” for heterozygous, or “2” for mutant homozygous.   
The original researchers analyzed each gene separately (Romeo, et al., 2007; Romeo, et 
al., 2009).  They also did not use all 282 mutations found in the genotype file.  Only 
nonsynonymous sequence variants were considered for analysis.  In addition to excluding 
individuals in the middle 50% of the distribution, variants that contained individuals in both the 
top and bottom quartiles of adjusted plasma triglycerides were also excluded.  A list of the 
variants in the reduced data set is provided in Romeo et. al. 2009.  Table 5.1 below gives the 
number of variants for the full and reduced data sets.   Of the 88 variants in the ANGPTL3 gene 
only 17 were included in the original analysis.  For the ANGPTL4 gene only 14 of the 94 variants 
were used.  Only nine of the 100 variants in the ANGPTL5 gene were utilized in the original test.  
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For comparison purposes the proposed methods were applied to both the full set and reduced set 
of variants for each gene.  It should be noted that for the reduced set of variants the MAF’s are all 
less than 0.1%. 
  Number of Variants 
Gene Full Reduced 
ANGPTL3 88 17 
ANGPTL4 94 14 
ANGPTL5 100 9 
Table 5.1: Number of Variants in the Full and Reduced Data Sets 
Price and authors (2010) took a different approach when analyzing the data set.  Rather 
than analyzing each gene individually they applied their methods to the whole data set.  They did 
not specify whether they used the full set of variants or the reduced set of variants.  Additionally 
they excluded individuals in the ethnic group “Other”.  Although analyzing each gene 
individually is more informative, for comparison purposes the proposed tests were run using all 
three genes together with the ethnic group “Other” excluded.  Both the full set and reduced set 
were considered in this analysis. 
5.3 Results 
For information purposes the MNWSS and SMA were first run on the full variant sets for 
each gene.  This approach represents a naïve use of the data and does not require any information 
on the type or functionality of the mutations.  Results for the full and reduced data sets by gene 
are provided in table 5.2.  For the MNWSS none of the tests are significant after correcting for 
multiple tests.  The observed significance levels for ANGPTL3, ANGPTL4, and ANGPTL5 
genes were 0.2646, 0.4454, and 0.0237 respectively.  For the SMA none of the tests produced a 
decision to reject the null hypothesis of no association after adjusting for the multiple tests.  Since 
the original studies only considered the reduced set of variants, a comparison cannot be made 
with these observed significance levels.   
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    Data Set 
Gene Method Full Reduced 
ANGPTL3 MNWSS 0.2624 0.0165 
 
SMA All "Do Not Reject" All "Do Not Reject" 
  Romeo, et. al. 2009   0.064 
ANGPTL4 MNWSS 0.4454 0.0044 
 
SMA All "Do Not Reject" All "Do Not Reject" 
  Romeo, et. al. 2007   0.016 
ANGPTL5 MNWSS 0.0237 0.119 
 
SMA All "Do Not Reject" All "Do Not Reject" 
  Romeo, et. al. 2009   0.022 
Table 5.2: Results for the Full and Reduced Data Sets by Gene 
The original study only provides results for the reduced set of variants.  They also did not 
account for the multiple tests being simultaneously performed.  For the ANGPTL3 gene the 
researchers report an observed significance level of 0.064 for the test of association (Romeo, et 
al., 2009).  Although this is not significant at the researchers’ chosen 0.05 level it is close to 
significance.  The MNWSS run on the reduced set produces a p-value of 0.0165 for the test of 
association between the ANGPTL3 gene and triglycerides.  The SMA did not produce any 
decisions to reject.  The original study reports a p-value of 0.016 for the test of association 
between the ANGPTL4 gene and triglycerides (Romeo, et al., 2007).  The MNWSS run on the 
reduced set of variants in the ANGPTL4 gene produces a p-value of 0.0044.  The SMA did not 
produce any decisions to reject.  For the ANGPTL5 gene the original study reports a p-value of 
0.022 for their test of association (Romeo, et al., 2009).  The MNWSS gains an observed 
significance level of 0.1190 when run on this reduced set.  The SMA again did not produce any 
decisions to reject the null hypothesis of no association.  The original researchers did not correct 
for the multiple tests being performed.  If they had used the Benjamini and Hochberg (1995) FDR 
controlling method on the three tests considered here they would have found the results of the 
tests for the ANGPTL4 and ANGPTL5 genes significant.  The observed significance levels for  
the MNWSS for the ANGPTL3 and ANGPTL4 genes are significant after using the Benjamini 
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and Hochberg (1995) FDR controlling method to account for the multiple tests.  Also the 
MNWSS yields p-values below the reported p-values in the original studies for these two genes.  
The SMA did not find any significant associations for any of the genes.  Further inspection shows 
that the individual tests in the SMA tend to yield high p-values.  It should be noted here that the 
data set analyzed by the proposed methods may be slightly different from the one used in the 
original study.  Since information on diabetes and alcohol consumption is not contained in the 
data set analyzed by the proposed methods, individuals excluded in the original analysis may be 
included for the new results.  This could result in some differences between the results of the 
original studies and the results of the proposed methods. 
As mentioned before Price et al. did not consider the genes separately but rather ran one 
test combining all three genes (2010).  They also did not relay whether they used the full or the 
reduced set of genes or whether they excluded individuals taking statins.  Their work proposes 
five different tests of association for case control data.  Their results (assuming the reduced data 
set) and the results of the proposed methods are presented in table 5.3.  Their proposed fixed 
threshold tests produced p-values of 0.013 for a one percent threshold and 0.00007 for a five 
percent threshold.  Price et al.’s weighted approach yields a p-value of 0.0020.  Their variable 
threshold test outputs a p-value of 0.00038.  Their recommended variable threshold test plus 
Polyphen weights yields a p-value of 0.00002.  Now consider the tests proposed in this work.  
The SMA did not produce any rejections of the null hypotheses of no association for either the 
full or reduced set of variants.  Using the full set of variants the MNWSS finds a p-value of 
0.1092 when all three genes are combined.  Running the MNWSS test on only the reduced set of 
variants with all three genes together produces a p-value of 0.00000393.  These results suggest 
that Price et al. (2010) uses only the reduced set of variants when running their analyses since 
their weighed approach is very similar to Madsen and Browning’s (2009).  Comparing the results 
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for the reduced set of variants, the MNWSS has a p-value lower than any of the tests proposed by 
Price et al.  
  Data Set 
Method Full Reduced 
MNWSS 0.1092 0.00000393 
SMA All "Do Not Reject" All "Do Not Reject" 
Fixed Threshold 1%† 
 
0.013 
Fixed Threshold 5%† 
 
0.00007 
Weigthed† 
 
0.002 
Variable Threshold† 
 
0.00038 
Variable Threshold + Polyphen†   0.00002 
†Price, et. al. 2010 
  Table 5.3: Results of Combining All Genes in the Full and Reduced Data Sets 
5.4 Discussion 
 This chapter demonstrates that the proposed methods are viable for data analysis.  The 
MNWSS was able to detect associations in two of the three genes at a 0.05 level after adjusting 
for the multiple tests.  The original studies report associations in two of the three genes at a 0.05 
level without adjusting for multiple tests.  Additionally for the genes where the MNWSS 
produces a significant result, the p-values are smaller than the p-values from the original studies.  
When the MNWSS is applied to all three genes together on the reduced set of variants the result 
is more significant than any of the results presented by Price and authors (2010) in their analysis 
of the data.   
 The SMA did not produce any decisions to reject the null hypothesis of no association 
after correcting for multiple tests.  Further analysis revealed that the individual p-values at each 
variant were high.  Thus no one variant is strongly associated with plasma triglyceride levels.  
Rather collectively the rare variants are associated with the phenotype.   
Comparing the results for the full and reduced set of variants highlights the importance of 
choosing which variants to include in the test.  The reduced set excludes synonymous variants 
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which do not alter the resulting protein structure and hence are not likely to have an effect.  The 
reduced set also excludes variants for which there are individuals in both the top and bottom 
quartiles that had the mutation.  This in effect excluded all of the common variants.  This cherry 
picking of variants reversed the decisions on all of the tests for the MNWSS.  For the ANGPTL3 
and ANGPTL4 genes the p-values were reduced from 0.2646 to 0.0165 and from 0.4454 to 
0.0044 by selecting variants for inclusion in the test.  On the other hand for the ANGPTL5 gene 
the p-value was increased from 0.0237 to 0.1190.  Recall for this gene that 100 different 
mutations were collected.  However, only nine of them made it into the reduced set of variants.  
In this case the researchers may have thrown out some important mutations.  
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CHAPTER VI 
 
 
CONCLUSIONS 
 
 This dissertation study investigated three new methods to test for an association between 
a nominal phenotype and multiple rare variants.  Since methods in this area were lacking the 
proposed methods came from extending methods currently used to test for an association between 
a dichotomous phenotype and multiple rare variants.  The methods proposed and evaluated here 
provide a starting point into association analysis for data with a multinomial phenotype and 
multiple rare variants.   
There is still room for a great deal of exploration in this area.  Since the inception of this 
project there has been an explosion of methods for association between a dichotomous phenotype 
and multiple rare variants.  Many of these methods could be extended to the case of a multinomial 
phenotype.  Also this project encountered difficulties in using multinomial logistic regression as a 
method of association.  Collapsing of variants with quasi-complete separation was tested as a 
quick fix to the problems.  However this fix did not solve all of the issues.  Additional 
modifications to multinomial logistic regression are necessary for it to be a viable method of 
association.  There are many variations on logistic regression to test for association between a 
dichotomous phenotype and multiple rare variants (Basu & Pan, 2011).  Some of these methods 
might be modified for the multinomial case. 
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The methods proposed here ignored possible epistasis, or interactions between variants.  
This assumption is common in rare variant association methods.  Research into how rare variant 
methods behave in the presence of epistasis is needed. 
Another area that needs to be addressed in methods of rare variant analysis is the 
inclusion of covariates.  Most data sets contain covariates such as age, gender, and ethnicity that 
affect the phenotype.  Neither of the proposed methods can accommodate covariates.  There are 
methods of rare variant analysis for dichotomous and quantitative phenotypes that can include 
covariates.  For dichotomous phenotypes the weighted SSU test with permutations (Basu & Pan, 
2011) and kernel-machine test (Wu, et al., 2010) specifically allow for including multiple 
covariates.  For quantitative phenotypes Morris and Zeggini’s (2010) tests can include covariates.  
However these methods may not be suited to all data sets.  For example the SSU test with 
permutations and the kernel-machine test are both very computationally intensive.  These 
methods would not be suited for analyzing a large data set.  Rare variant analysis methods for 
both dichotomous and multinomial phenotypes that can include covariates without computational 
complexity would be extremely useful. 
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APPPENDICES 
 
 
 
Table A.1: Power Comparison for a Sample Size of 500  
    Lambda 
Categories Method 0.01 0.05 0.1 0.2 0.3 0.5 0.8 
3 MNWSS 0.086 0.271 0.51 0.735 0.869 0.944 0.963 
 
MNWSSP 0.086 0.277 0.506 0.739 0.869 0.944 0.963 
 
SMA 0.023 0.2 0.616 0.974 1 1 1 
 
MLOGIT 0.454 0.781 0.9599† 1.0† 1 1.0† 1.0† 
  MLOGITC 0.057 0.257 0.661 0.9590† 0.997 0.999 0.998 
5 MNWSS 0.078 0.238 0.454 0.732 0.871 0.967 0.98 
 
MNWSSP 0.078 0.239 0.453 0.732 0.874 0.965 0.98 
 
SMA 0.014 0.172 0.591 0.97 1 1 1 
 
MLOGITC 0.0250† 0.188 0.505 0.833 0.963 0.9940† 0.9990† 
7 MNWSS 0.073 0.214 0.406 0.724 0.87 0.95 0.98 
 
MNWSSP 0.073 0.216 0.408 0.731 0.875 0.951 0.98 
 
SMA 0.022 0.141 0.505 0.956 0.997 1 1 
  MLOGITC 0.019 0.114 0.292 0.6167† 0.855 0.9920† 0.9970† 
†A portion of these tests failed and the results are most likely biased 
MNWSS = Multinomial Weighted Sum Statistic, MNWSSP = Multinomial Weighted Sum Statistic with 
Permutation Test, SMA = Single Marker Analysis, MLOGIT = Multinomial Logistic Regression, 
MLOGITC = Multinomial Logistic Regression with Collapsing of Variants with Quasi-Complete 
Separation 
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Table A.2: Power Comparison for a Sample Size of 1000 
    Lambda 
Categories Method 0.01 0.05 0.1 0.2 0.3 0.5 0.8 
3 MNWSS 0.131 0.471 0.765 0.932 0.961 0.989 0.987 
 
MNWSSP 0.134 0.473 0.758 0.933 0.961 0.989 0.985 
 
SMA 0.039 0.609 0.972 1 1 1 1 
 
MLOGIT 0.355 0.84 0.997 1.0† 1.0† 1.0† 1.0† 
  MLOGITC 0.056 0.577 0.974 1 1 1 1 
5 MNWSS 0.105 0.417 0.746 0.913 0.976 0.991 0.995 
 
MNWSSP 0.109 0.423 0.744 0.911 0.974 0.991 0.995 
 
SMA 0.046 0.563 0.969 1 1 1 1 
 
MLOGITC 0.053 0.557 0.951 0.999 1 1 1.0† 
7 MNWSS 0.102 0.379 0.685 0.909 0.956 0.985 0.989 
 
MNWSSP 0.104 0.385 0.681 0.904 0.956 0.986 0.989 
 
SMA 0.039 0.509 0.948 1 1 1 1 
  MLOGITC 0.0662† 0.4769† 0.8739† 0.9990† 1.0† 1.0† 1.0† 
†A portion of these tests failed and the results are most likely biased 
MNWSS = Multinomial Weighted Sum Statistic, MNWSSP = Multinomial Weighted Sum Statistic with 
Permutation Test, SMA = Single Marker Analysis, MLOGIT = Multinomial Logistic Regression, 
MLOGITC = Multinomial Logistic Regression with Collapsing of Variants with Quasi-Complete 
Separation 
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Table A.3: Power Comparison for a Sample Size of 2000 
    Lambda 
Categories Method 0.01 0.05 0.1 0.2 0.3 0.5 0.8 
3 MNWSS 0.214 0.728 0.913 0.981 0.994 0.992 0.999 
 
MNWSSP 0.22 0.727 0.911 0.98 0.993 0.992 0.999 
 
SMA 0.161 0.965 1 1 1 1 1 
 
MLOGIT 0.415 0.969† 0.9990† 1 1.0† 1.0† 1.0*† 
  MLOGITC 0.1 0.941 1 1 1 1.0† 1 
5 MNWSS 0.189 0.68 0.898 0.972 0.985 0.997 0.998 
 
MNWSSP 0.187 0.685 0.897 0.973 0.985 0.997 0.998 
 
SMA 0.121 0.962 1 1 1 1 1 
 
MLOGITC 0.114 0.938 1 1 1 1 1.0† 
7 MNWSS 0.149 0.653 0.886 0.974 0.988 0.994 0.997 
 
MNWSSP 0.153 0.662 0.886 0.972 0.989 0.994 0.998 
 
SMA 0.115 0.935 1 1 1 1 1 
  MLOGITC 0.1247† 0.9057† 0.9990† 1.0† 1.0† 1.0† 1.0† 
†A portion of these tests failed and the results are most likely biased 
MNWSS = Multinomial Weighted Sum Statistic, MNWSSP = Multinomial Weighted Sum Statistic with 
Permutation Test, SMA = Single Marker Analysis, MLOGIT = Multinomial Logistic Regression, 
MLOGITC = Multinomial Logistic Regression with Collapsing of Variants with Quasi-Complete 
Separation 
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Table A.4: Power versus Sample Size for a Heritability of 5% 
    Sample Size 
Categories Method 500 1000 1500 2000 2500 3000 
3 MNWSS 0.271 0.471 0.613 0.728 0.796 0.849 
 
MNWSSP 0.277 0.473 0.612 0.727 0.799 0.848 
 
SMA 0.200 0.609 0.934 0.965 0.996 0.999 
5 MNWSS 0.238 0.417 0.599 0.680 0.777 0.852 
 
MNWSSP 0.239 0.423 0.604 0.685 0.780 0.850 
 
SMA 0.172 0.563 0.865 0.962 0.990 0.998 
7 MNWSS 0.214 0.379 0.532 0.653 0.770 0.800 
 
MNWSSP 0.216 0.385 0.526 0.662 0.768 0.801 
  SMA 0.141 0.509 0.804 0.935 0.980 0.998 
 
Table A.5: Power versus Sample Size for a Heritability of 10% 
    Sample Size 
Categories Method 500 750 1000 1500 2000 
3 MNWSS 0.510 0.632 0.765 0.861 0.913 
 
MNWSSP 0.506 0.633 0.758 0.867 0.911 
 
SMA 0.616 0.879 0.927 0.998 1.000 
5 MNWSS 0.454 0.593 0.746 0.852 0.898 
 
MNWSSP 0.453 0.594 0.744 0.851 0.897 
 
SMA 0.591 0.859 0.969 1.000 1.000 
7 MNWSS 0.406 0.540 0.685 0.807 0.886 
 
MNWSSP 0.408 0.548 0.681 0.804 0.886 
  SMA 0.505 0.806 0.948 0.999 1.000 
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Table A.6: Power versus Sample Size for a Heritability of 20% 
    Sample Size 
Categories Method 500 750 1000 2000 
3 MNWSS 0.735 0.868 0.932 0.981 
 
MNWSSP 0.739 0.866 0.933 0.980 
 
SMA 0.974 0.997 1.000 1.000 
5 MNWSS 0.732 0.851 0.913 0.972 
 
MNWSSP 0.732 0.846 0.911 0.973 
 
SMA 0.970 0.999 1.000 1.000 
7 MNWSS 0.724 0.827 0.909 0.974 
 
MNWSSP 0.731 0.827 0.904 0.972 
  SMA 0.956 1.000 1.000 1.000 
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addressed.  The purpose of this study is to develop new methods of rare variant 
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Findings and Conclusions:   
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association analysis with multinomial phenotypes.  These methods have the correct or 
conservative Type I error rate and reasonable power for large samples with a moderate 
heritability.  The viable methods are applied to resequencing data from the Dallas Heart 
Study.  One of the methods detected an association between a categorized plasma 
triglyceride level and the ANGPTL3 and ANGPTL4 genes. 
 
